US20110093083A1 - Distal femoral knee prostheses - Google Patents

Distal femoral knee prostheses Download PDF

Info

Publication number
US20110093083A1
US20110093083A1 US12/974,018 US97401810A US2011093083A1 US 20110093083 A1 US20110093083 A1 US 20110093083A1 US 97401810 A US97401810 A US 97401810A US 2011093083 A1 US2011093083 A1 US 2011093083A1
Authority
US
United States
Prior art keywords
prostheses
overall
dimension
sets
competitive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/974,018
Inventor
Brian D. Earl
Abraham P. Habegger
Aaron A. Hofmann
Kim C. Bertin
Lawrence Dorr
Robert E. Booth
Aaron Rosenberg
Sergio Romagnoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zimmer Inc
Original Assignee
Zimmer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US75061305P priority Critical
Priority to US80593306P priority
Priority to US11/611,021 priority patent/US9592127B2/en
Priority to US11/780,248 priority patent/US20080058947A1/en
Application filed by Zimmer Inc filed Critical Zimmer Inc
Priority to US12/974,018 priority patent/US20110093083A1/en
Publication of US20110093083A1 publication Critical patent/US20110093083A1/en
Application status is Abandoned legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/38Joints for elbows or knees
    • A61F2/3859Femoral components
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30317The prosthesis having different structural features at different locations within the same prosthesis
    • A61F2002/30324The prosthesis having different structural features at different locations within the same prosthesis differing in thickness
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30535Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30604Special structural features of bone or joint prostheses not otherwise provided for modular
    • A61F2002/30616Sets comprising a plurality of prosthetic parts of different sizes or orientations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30667Features concerning an interaction with the environment or a particular use of the prosthesis

Abstract

A set of distal femoral knee prostheses which are designed to be more narrow in medial/lateral dimensions with increasing anterior/posterior size than existing prostheses to more closely correspond to the physical anatomy of female patients. The prostheses are designed to have a substantially trapezoidal shape or profile when viewed distally which features a more pronounced narrowing of the medial/lateral dimensions beginning at the posterior end of the prostheses and progressing anteriorly to the anterior end of the prostheses. Additionally, the prostheses each include a reduced profile patellar sulcus and reduced profile anterior condyles to more closely conform to the anatomy of a resected femur, and also include sulcus tracking optimized to conform to female anatomy.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation-in-part of U.S. patent application Ser. No. 11/611,021, filed Dec. 14, 2006, entitled Distal Femoral Knee Prostheses, which claims the benefit under Title 35, U.S.C. §119(e) of U.S. Provisional Patent Application Ser. No. 60/750,613, entitled Distal Femoral Knee Prostheses, filed Dec. 15, 2005, and U.S. Provisional Patent Application Ser. No. 60/805,933, entitled Distal Femoral Knee Prostheses, filed Jun. 27, 2006. This application hereby expressly incorporates by reference herein the entire disclosures of U.S. patent application Ser. No. 11/611,021, filed Dec. 14, 2006; U.S. Provisional Patent Application Ser. No. 60/750,613, filed Dec. 15, 2005; and U.S. Provisional Patent Application Ser. No. 60/805,933, filed Jun. 27, 2006.
  • This application claims the benefit under Title 35, U.S.C. §119(e) of U.S. Provisional Patent Application Ser. No. 60/914,359, entitled Distal Femoral Knee Prostheses, filed Apr. 27, 2007, the disclosure of which is hereby expressly incorporated herein by reference.
  • BACKGROUND
  • 1. Field of the Invention
  • The present invention relates generally to orthopedic prosthetic devices and, in particular, to distal femoral knee prostheses.
  • 2. Description of the Related Art
  • Disease and trauma affecting the articular surfaces of a knee joint are commonly effectively treated by surgically replacing the articulating ends of the femur and tibia with prosthetic femoral and tibial implants or prostheses according to a procedure known as a total knee replacement (“TKR”) or a total knee arthroplasty (“TKA”). The femoral and tibial implants are made of materials that exhibit a low coefficient of friction as they articulate against one another to restore normal knee function.
  • Although distal femoral knee prostheses are provided in a range of varying sizes and are selected by surgeons to best fit the anatomy of a particular patient, improvements in the design of distal femoral knee prostheses are desired.
  • SUMMARY
  • The present invention provides a set of distal femoral knee prostheses which are designed to be more narrow in medial/lateral (“M/L”) dimensions with increasing anterior/posterior (“A/P”) size than existing prostheses to more closely correspond to the physical anatomy of female patients. The prostheses are designed to have a substantially trapezoidal shape or profile when viewed distally which features a more pronounced narrowing of the M/L dimensions beginning at the posterior end of the prostheses and progressing anteriorly to the anterior end of the prostheses. Additionally, the prostheses each include a reduced profile patellar sulcus and reduced profile anterior condyles to more closely conform to the anatomy of a resected femur, and also include sulcus tracking which is optimized to conform to female anatomy.
  • In one form thereof, the present disclosure provides a set of distal femoral prostheses particularly adapted for female anatomy, each femoral prosthesis including a distal nonarticulating surface having an anterior end and a posterior end, including a plurality of prostheses each having an overall anterior/posterior dimension defined between points located most anteriorly and most posteriorly on each prosthesis and a medial/lateral dimension defined between points located most medially and most laterally at anterior/posterior locations defined by the anterior end of the distal nonarticulating surface on each prosthesis; at least some of the prostheses having an overall anterior/posterior dimension and a medial/lateral dimension falling below a conceptual boundary defined by a line connecting a first point and a second point, the first point having an approximately 52.0 mm overall anterior/posterior dimension and an approximately 49.0 mm medial/lateral dimension, and the second point having an approximately 77.0 mm overall anterior/posterior dimension and an approximately 67.0 mm medial/lateral dimension; wherein the line is defined by the following equation: (medial/lateral dimension)=(0.72*overall anterior/posterior dimension)+11.56.
  • In another form thereof, the present disclosure provides a set of distal femoral prostheses particularly adapted for female anatomy, each femoral prosthesis including a distal nonarticulating surface having an anterior end and a posterior end, including a plurality of prostheses each having an overall anterior/posterior dimension defined between points located most anteriorly and most posteriorly on each prosthesis and a medial/lateral dimension defined between points located most medially and most laterally at anterior/posterior locations substantially equidistant from the anterior end of the distal nonarticulating surface and the posterior end of the distal nonarticulating surface; at least some of the prostheses having an overall anterior/posterior dimension and a medial/lateral dimension falling below a conceptual boundary defined by a line connecting a first point and a second point, the first point having an approximately 52.0 mm overall anterior/posterior dimension and an approximately 55.0 mm medial/lateral dimension, and the second point having an approximately 77.0 mm overall anterior/posterior dimension and an approximately 78.5 mm medial/lateral dimension; wherein the line is defined by the following equation: (medial/lateral dimension)=(0.94*overall anterior/posterior dimension)+6.12.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The above-mentioned and other features and advantages of this invention, and the manner of attaining them, will become more apparent and the invention itself will be better understood by reference to the following description of embodiments of the invention taken in conjunction with the accompanying drawings, wherein:
  • FIG. 1 is a side view of an exemplary distal femoral prosthesis in accordance with the present invention;
  • FIG. 2 is another side view of the prosthesis of FIG. 1, illustrating certain dimensions thereof;
  • FIG. 3 is a distal view of the prosthesis of FIG. 2, viewed along line 3-3 of FIG. 2 and shown superimposed on a prosthesis;
  • FIG. 4 further illustrates the anatomical M/L vs. A/P dimensional relationship of the prosthesis of FIG. 3 at dimension “B-B”;
  • FIG. 5 is a graph illustrating a representative anatomical mid-box M/L vs. A/P dimensional relationship with respect to male and female femurs of various size;
  • FIG. 5A is a view of an anatomic overall A/P dimension for a representative femur;
  • FIG. 5B is a view of an anatomic mid-box M/L dimension for a representative femur;
  • FIG. 6 is a graph of mid-box M/L vs. overall A/P for prostheses designed in accordance with the present invention as compared with several prostheses;
  • FIG. 7 is a graph of anterior M/L along a dimension “B-B” vs. overall A/P for prostheses designed in accordance with the present invention as compared with several prostheses;
  • FIG. 8 is a graph of posterior M/L vs. overall A/P for prostheses designed in accordance with the present invention as compared with several prostheses;
  • FIG. 9 is a graph of the ratio of (mid-box M/L/overall A/P) vs. overall A/P for the prostheses of FIG. 6;
  • FIG. 10 is a graph of the ratio of (anterior M/L along dimension “B-B”/overall A/P) vs. overall A/P for the prostheses of FIG. 7;
  • FIG. 11 is a graph of the ratio of (posterior M/L/overall A/P) vs. overall A/P for the prostheses of FIG. 8;
  • FIG. 12 is a distal view of an exemplary prosthesis designed in accordance with the present invention, shown superimposed on another prosthesis and illustrating the profiles and the distal taper angles of same;
  • FIG. 13 is a graph of distal taper angle vs. overall A/P for prostheses designed in accordance with the present invention as compared with several prostheses;
  • FIG. 14 is a distal view of an exemplary prosthesis;
  • FIG. 15 is a side view of the prosthesis of FIG. 14, illustrating the recessed patellar sulcus thereof as compared with another prosthesis;
  • FIG. 16 is another side view of the prosthesis of FIG. 14, illustrating the reduced profile of the anterior condyles thereof as compared with another prosthesis;
  • FIG. 17A is an A/P view of a prosthesis having conventional sulcus tracking;
  • FIG. 17B is an A/P view of an exemplary prosthesis in accordance with the present invention having a more lateralized sulcus tracking;
  • FIG. 18 is a graph of A-A M/L vs. overall A/P for prostheses designed in accordance with the present invention as compared with several prostheses; and
  • FIG. 19 is a graph of the ratio of (A-A M/L/overall A/P) vs. overall A/P for the prostheses of FIG. 18.
  • Corresponding reference characters indicate corresponding parts throughout the several views. The exemplifications set out herein illustrate exemplary embodiments of the invention, and such exemplifications are not to be construed as limiting the scope of the invention any manner.
  • DETAILED DESCRIPTION
  • As used herein, the following directional definitions apply. Anterior and posterior mean nearer the front or nearer the rear of the body, respectively. Thus, with respect to the prostheses described herein, anterior refers to that portion of the knee that is nearer the front of the body, when the leg is in an extended position. Proximal and distal mean nearer to or further from the root of a structure, respectively. For example, the distal femur is a part of the knee joint while the proximal femur is part of the hip joint. Finally, the adjectives medial and lateral mean nearer the sagittal plane or further from the sagittal plane, respectfully. The sagittal plane is an imaginary vertical plane through the middle of the body that divides the body into right and left halves.
  • Distal femoral knee prostheses made in accordance with the present invention are intended to be used to restore knee joint function in patients with severe pain and disability due, for example, to Rheumatoid arthritis, osteoarthritis, traumatic arthritis polyarthritis; collagen disorders, and/or avascular necrosis of the femoral condyle; post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy; moderate valgus, varus, flexion deformities, or other conditions.
  • Referring initially to FIG. 1, a distal femoral prosthesis 50 for a TKR/TKA according to one embodiment of the present invention is shown, and generally includes an external articulating surface 52 and a bone contacting non-articulating internal surface 54. Articulating surface 52 includes an anterior articulating surface 56, a distal articulating surface 58, a lateral posterior condylar articulating surface 60, and a medial posterior condylar articulating surface 62. Prosthesis 50 may be made of any biocompatible material having the mechanical properties necessary to function as a human knee distal femoral prosthesis. Preferably, prosthesis 50 is made of titanium, titanium alloy, cobalt chrome alloy, stainless steel, or a ceramic. Referring additionally to FIG. 3, prosthesis 50 further includes patellar flange 64 including lateral and medial anterior condyles 66 and 68, respectively, as well as patellar sulcus 70 disposed between lateral and medial anterior condyles 66 and 68. Prosthesis 50 also includes lateral and medial posterior condyles 72 and 74, respectively.
  • Referring to FIG. 1, the internal non-articulating portion 54 of prosthesis 50 is adapted to receive a resected distal femur. The surgical cuts made to the distal femur can be made by any means, in any sequence and in any configuration known to those of skill in the art of knee arthroplasty. Exemplary cut guides and processes for resecting the distal femur are shown and described in U.S. patent application Ser. No. 11/151,062, entitled ADJUSTABLE CUT GUIDE, filed on Jun. 13, 2005 (Attorney Docket Ref.: ZIM0231) and U.S. patent application Ser. No. 11/154,774, entitled MULTI-POSITIONABLE CUT GUIDE, filed on Jun. 16, 2005 (Attorney Docket Ref.: ZIM0234), assigned to the assignee of the present invention, the disclosures of which are expressly incorporated herein by reference.
  • In a preferred embodiment, prosthesis 50 comprises a plurality of chamfer surfaces corresponding to a plurality of chamfer surfaces or “box cuts” made in the distal femur. Non-articular surface 54 may comprise a porous metal surface or any surface likely to promote the growth of bone therein. Non-articular surface 54 of prosthesis 50 preferably comprises anterior non-articular surface 76, distal anterior non-articular surface 78, distal non-articular surface 80, two distal posterior non-articular surfaces 82, and two posterior non-articular surfaces 84.
  • Distal non-articular surface 80 is generally flat and adapted to receive the distal-most surface of the resected femur. Distal non-articular surface 80 comprises an anterior end and a posterior end. The anterior end of distal non-articular surface 80 abuts one end of distal anterior non-articular surface 78, which surface 78 also includes an anterior end and a posterior end. Surface 78 extends from surface 80 anteriorly and superiorly such that an obtuse angle is formed between surfaces 78 and 80. Anterior non-articular surface 76 extends superiorly from the anterior end of surface 78.
  • The posterior end of distal non-articular surface 80 abuts one end of each distal posterior non-articular surface 82, which surfaces 82 also include an anterior end and a posterior end. Surfaces 82 extend from surface 80 posteriorly and superiorly such that an obtuse angle is formed between surfaces 82 and 80. Posterior non-articular surfaces 84 extend superiorly from the posterior ends of surfaces 82, respectively.
  • As discussed in detail below, for many patients, particularly female patients, it is desirable to construct a set of prostheses 50 of varying size wherein the medial/lateral (“M/L”) width dimensions of the prostheses correspond more closely to the actual anatomical M/L width dimensions of the female femur and articulating surfaces. As described below, prostheses 50 addresses this concern by offering the surgeon a set of narrower prostheses in the M/L dimensions for a given set of anterior/posterior (“A/P”) prosthesis sizes which will allow the surgeon to use a prosthesis with both a correct A/P size and more accurate and optimized M/L dimensions to provide optimal prosthesis sizing and joint kinematics as compared to conventional prostheses.
  • In FIG. 3, the profile 86 of prosthesis 50 is superimposed upon profile 88 of another prosthesis. As described in detail below, prosthesis 50 has a unique, substantially trapezoidal shape or profile 86 when viewed distally with a more pronounced narrowing of the M/L dimensions as compared to the shape or profile 88 of the other prosthesis starting, with reference to the resected femur, at the posterior distal facet and progressing anteriorly to the anterior distal facet. Referring to FIGS. 2 and 3, prosthesis 50 is shown and is characterized below with reference to the following directions: anterior “A”, posterior “P”, distal “D”, proximal “PR”, medial “M” and lateral “L”, as well as the following dimensions. Dimension “Posterior” is the M/L width at the widest point across the posterior condyles 72, 74 of prosthesis 50. Dimension “C-C” is the M/L width at the junction of the posterior distal facet and the distal plane, i.e., the M/L width along the intersection between distal non-articular surface 80 and distal posterior non-articular surfaces 82. Dimension “B-B” is the M/L width at the junction of the distal plane and the distal anterior facet, i.e., the M/L width along the intersection between distal non-articular surface 80 and distal anterior non-articular surface 78. Dimension “A-A” is the M/L width at the junction of the distal anterior facet and the posterior side of the anterior flange, i.e., the M/L width along the intersection of distal anterior non-articular surface 78 and anterior non-articular surface 76. Dimension “MB” is the M/L width at a “mid-box” point of prosthesis 50, i.e., along a line located on distal non-articular surface 80 substantially midway between Dimension C-C and Dimension B-B.
  • As described below, the profiles of a set of prostheses 50 can also be described in terms of an increasing narrowing of the M/L dimensions relative to other prostheses on a per size basis. It has been observed that, for given female femurs, for example, the M/L dimensions are sometimes smaller than those of other prostheses of the proper A/P dimension. This discrepancy is small on the smaller A/P size prostheses and increases as the A/P size increases. For example, referring to FIG. 5, a representative mid-box M/L vs. A/P dimensional relationship with respect to the actual human anatomy of distal femurs for males and females is shown. Representative female data is generally grouped together at lower values of mid-box M/L and representative male data is generally grouped together at higher values of mid-box M/L. Best fit lines for female and male data have been included on FIG. 5 to show the general trend of representative mid-box M/L dimensions. As may be seen from FIG. 5, there exists a clear distinction between the representative M/L dimension vs. the A/P dimension for a female distal femur as compared to a male distal femur. FIGS. 5A and 5B show exemplary anatomic overall A/P and mid-box M/L dimensions for a representative femur.
  • In FIG. 2, the overall A/P (“Overall A/P”) dimension is the distance between two lines perpendicular to distal non-articular surface 80 that pass through the most posterior point on the posterior face of exterior articulating surface 58 and through the most anterior point on the anterior face of exterior articulating surface 58, respectively. FIG. 2 also shows a dashed outline of a resected femur with prosthesis 50 positioned thereon.
  • As an exemplary comparison, the dimensions “Posterior”, “B-B”, “A-A”, and “Overall A/P” and the ratios of these values for conventional prostheses (“Conventional 1”, including five increasing sizes C through G) are compared with corresponding dimensions and ratios of a set of prostheses designed in accordance with the present invention (“Embodiment 1”, including five increasing sizes C through G). These values are presented in Table 1 below. Unless otherwise indicated, all numerical dimensional values presented herein are in millimeters (“mm”)
  • TABLE 1 Overall “B- “A- Overall “B- “A- SIZE A/P “Post.” B” A” A/P “Post.” B” A” Embodiment 1 Conventional 1 C 52.2 58.0 49.6 41.1 53.5 60.0 53.6 45.1 D 56.3 61.3 51.5 42.6 57.6 64.0 55.8 46.5 E 60.2 64.5 53.5 43.7 61.5 68.0 59.3 49.1 F 64.2 67.9 55.4 45.0 65.4 72.0 63.2 52.0 G 69.2 71.0 57.3 46.3 70.4 76.5 67.3 56.2 Embodiment 1 - Conventional 1 - M/L/“Overall M/L/“Overall A/P” RATIOS A/P” RATIOS C 52.2 1.11 0.95 0.79 53.5 1.12 1.00 0.84 D 56.3 1.09 0.92 0.76 57.6 1.11 0.97 0.81 E 60.2 1.07 0.89 0.73 61.5 1.11 0.96 0.80 F 64.2 1.06 0.86 0.70 65.4 1.10 0.97 0.79 G 69.2 1.03 0.83 0.67 70.4 1.09 0.96 0.80
  • Table 2 below sets forth the results of a first order equation fit to data sets for several sets of prostheses including Conventional 1, Conventional 2 (which is similar to Conventional 1), Embodiment 1, Embodiment 2 (which is similar to Embodiment 1), as well as five other sets of competitive prostheses, designated Competitive 1, Competitive 2, Competitive 3, Competitive 4, and Competitive 5. The data sets include Posterior M/L vs. Overall A/P and the Ratio (Posterior M/L vs. Overall A/P) vs. Overall A/P.
  • TABLE 2 Ratio (Posterior M/L/ Posterior M/L Overall A/P) vs. Overall A/P vs. Overall A/P Best fit regression line Best fit regression line Equation Slope Equation Slope Conventional 1 y = 0.9811x + 0.9811 y = −0.002x + −0.0020 7.595 1.2277 Conventional 2 y = 0.9878x + 0.9878 y = −0.0015x + −0.0015 6.0634 1.1798 Embodiment 1 y = 0.8036x + 0.8036 y = −0.0044x + −0.0044 16.228 1.3431 Embodiment 2 y = 0.809x + 0.8090 y = −0.0039x + −0.0039 14.987 1.2965 Competitive 1 y = 0.9411x + 0.9411 y = −0.0016x + −0.0016 7.1008 1.1565 Competitive 2 y = 0.987x + 0.9870 y = −0.0017x + −0.0017 6.8225 1.2015 Competitive 3 y = 0.976x + 0.9760 y = −0.0013x + −0.0013 5.7825 1.1521 Competitive 4 y = 0.9757x + 0.9757 y = −0.0016x + −0.0016 6.6279 1.1836 Competitive 5 y = 0.9336x + 0.9336 y = −0.0031x + −0.0031 11.318 1.3111
  • From the data in Table 2, it may be seen that there is a difference in the slopes of the sets of prostheses of Embodiments 1 and 2 as compared to the slopes of the sets of the other prostheses. In particular, it may be seen from the data in Table 2 that the sets of prostheses of Embodiments 1 and 2 have a narrowing posterior M/L dimension with increasing A/P size, as indicated by slopes less than 0.93, for example, as opposed to a substantially parallel or one-to-one relationship between the posterior M/L dimension and the A/P dimension with increasing A/P size as in the sets of other prostheses, as indicated by slopes of 0.93 and above. Thus, in the sets of other prostheses, the posterior M/L dimension and the A/P dimension increase at substantially the same rate with increasing A/P size. Also, the slope of the ratio (posterior M/L/overall A/P) vs. overall A/P is less than −0.0032 for the sets of prostheses of Embodiments 1 and 2 while the corresponding slope for the other sets of prostheses is greater than −0.0032, indicating that the sets of prostheses of Embodiments 1 and 2 have an increasingly more pronounced narrowing of the posterior M/L dimension with increasing A/P size. In this manner, the sets of prostheses designed in accordance with the present invention offer a surgeon a unique combination of implant posterior M/L widths with varying A/P size for an overall system or set of prostheses, wherein such sets of prostheses are more anatomically optimized for the female anatomy as compared with the sets of other prostheses.
  • Table 3 below sets forth the results of a first order equation fit to data sets for several sets of prostheses including Conventional 1, Conventional 2 (which is similar to Conventional 1), Embodiment 1, Embodiment 2 (which is similar to Embodiment 1), as well as five other sets of competitive prostheses, designated Competitive 1, Competitive 2, Competitive 3, Competitive 4, and Competitive 5. The data sets include B-B M/L vs. Overall A/P and the Ratio (B-B M/L vs. Overall A/P) vs. Overall A/P.
  • TABLE 3 Ratio (Anterior M/L “B-B”/ Anterior M/L “B-B” Overall A/P) vs. Overall A/P vs. Overall A/P Best fit regression line Best fit regression line Equation Slope Equation Slope Conventional 1 y = 0.834x + 8.3768 0.8340 y = −0.0023x + −0.0023 1.112 Conventional 2 y = 0.8432x + 0.8432 y = −0.0018x + −0.0018 6.9003 1.0681 Embodiment 1 y = 0.4626x + 0.4626 y = −0.0071x + −0.0071 25.012 1.3173 Embodiment 2 y = 0.4626x + 0.4626 y = −0.0066x + −0.0066 25.012 1.2797 Competitive 1 y = 0.9062x + 0.9062 y = −0.0007x + −0.0007 3.2306 1.0017 Competitive 2 y = 0.8057x + 0.8057 y = −0.0031x + −0.0031 12.588 1.2033 Competitive 3 y = 0.893x + 5.5381 0.8930 y = −0.0012x + −0.0012 1.0578 Competitive 4 y = 1.0588x + 1.0588 y = −0.0001x + −0.0001 0.1731 1.0697 Competitive 5 y = 0.7937x + 0.7937 y = −0.0036x + −0.0036 12.218 1.217
  • From the data in Table 3, it may be seen that there is a significant difference in slope for the sets of prostheses of Embodiments 1 and 2 as compared with the slopes of the other sets of prostheses. The magnitudes of the anterior M/L “B-B” values for a given A/P dimension are more pronounced, i.e., the variance in width at dimension B-B, namely, an anterior width, over various A/P sizes between the sets of prostheses of Embodiments 1 and 2 and the other sets of prostheses is more dramatically pronounced. Specifically, sets of prostheses of Embodiments 1 and 2 have a narrowing anterior M/L dimension with increasing A/P size, as indicated by slopes less than 0.78, for example, as opposed to a substantially parallel or one-to-one relationship between the anterior M/L dimension and the A/P dimension with increasing A/P size as in the sets of other prostheses, as indicated by slopes of 0.78 and above. Thus, in the sets of other prostheses, the anterior M/L dimension and the A/P dimension increase at substantially the same rate with increasing A/P size. Also, the slope of the ratio (anterior M/L “B-B”/overall A/P) vs. overall A/P is greater than −0.0038 for the sets of prostheses of Embodiments 1 and 2, while the corresponding slope for the other sets of prostheses is less than −0.0038, indicating that the sets of prostheses of Embodiments 1 and 2 have increasingly more pronounced narrowing of the anterior M/L “B-B” dimension with increasing A/P size. In this manner, the prostheses designed in accordance with the present invention offer a surgeon a unique combination of implant M/L widths as an overall system of prostheses, wherein such sets of prostheses are more anatomically optimized for the female anatomy as compared with the sets of other prostheses.
  • As another exemplary comparison, the dimensions “Posterior”, “MB”, “B-B”, and “Overall A/P” for conventional prostheses (“Conventional 3”, “Conventional 4”, and “Conventional 5” including five increasing sizes C through G) are compared with corresponding dimensions of a set of prostheses designed in accordance with the present invention (“Embodiment 3”, “Embodiment 4”, and “Embodiment 5” including five increasing sizes C through G). In one embodiment, the values for Conventional 5 and Embodiment 5 may be average values of Conventionals 3 and 4 and Embodiments 3 and 4, respectively. These values are presented in Table 4 below.
  • TABLE 4 SIZE Overall A/P Posterior MB B-B Overall A/P Posterior MB B-B Embodiment 4 Conventional 4 C 53.3 58.0 55.9 50.2 54.4 60.0 58.6 53.6 D 57.5 61.4 58.4 52.0 58.6 64.0 62.1 55.8 E 61.2 64.7 60.8 54.0 62.5 68.0 65.9 59.3 F 65.3 68.1 63.5 56.0 66.5 72.0 70.2 63.2 G 70.4 71.5 66.0 58.0 71.5 76.5 74.0 67.3 Embodiment 3 Conventional 3 C 52.3 58.0 55.9 50.2 53.5 60.0 58.6 53.6 D 56.4 61.4 58.4 52.0 57.6 64.0 62.0 55.7 E 60.2 64.7 60.8 54.0 61.5 68.0 65.9 59.3 F 64.2 68.1 63.5 56.0 65.5 72.0 70.2 63.2 G 69.4 71.5 66.0 58.0 70.5 76.5 74.0 67.2 Embodiment 5 Conventional 5 C 52.8 58.0 55.9 50.2 54.0 60.0 58.6 53.6 D 56.9 61.4 58.4 52.0 58.1 64.0 62.0 55.8 E 60.7 64.7 60.8 54.0 62.0 68.0 65.9 59.3 F 64.8 68.1 63.5 56.0 66.0 72.0 70.2 63.2 G 69.9 71.5 66.0 58.0 71.0 76.5 74.0 67.3
  • FIG. 6 is a graph of the dimension mid-box M/L vs. overall A/P for the following sets of prostheses, each in increasing sizes C through G: Conventional 5, Embodiment 5, as well as eight other sets of competitive prostheses, designated Competitive 1, Competitive 2, Competitive 3, Competitive 4, Competitive 5, Competitive 6, Competitive 7, and Competitive 8.
  • FIG. 7 is a graph of the dimension B-B M/L vs. overall A/P for the following sets of prostheses, each in increasing sizes C through G: Conventional 5, Embodiment 5, as well as eight other sets of competitive prostheses, designated Competitive 1, Competitive 2, Competitive 3, Competitive 4, Competitive 5, Competitive 6, Competitive 7, and Competitive 8.
  • FIG. 8 is a graph of the dimension Posterior M/L vs. overall A/P for the following sets of prostheses, each in increasing sizes C through G: Conventional 5, Embodiment 5, as well as eight other sets of competitive prostheses, designated Competitive 1, Competitive 2, Competitive 3, Competitive 4, Competitive 5, Competitive 6, Competitive 7, and Competitive 8.
  • Table 5 below sets forth the results of a first order equation fit to each of the data sets shown in FIGS. 6, 7, and 8 as well as for the data sets of Embodiment 5 and Conventional 5 in Table 4.
  • TABLE 5 Posterior Mid-box M/L vs. M/L vs. B-B M/L Overall A/P Overall A/P vs. Overall Best Fit Best Fit A/P Best Fit Regression Regression Regression Line Line Line Implant Slope y-Intercept Slope y-Intercept Slope y-Intercept Conventional 3 0.98 7.53 0.93 8.63 0.83 8.35 Conventional 4 0.98 6.82 0.93 8.02 0.83 7.66 Conventional 5 0.98 7.17 0.93 8.32 0.83 8.01 Embodiment 3 0.80 16.31 0.60 24.89 0.46 26.02 Embodiment 4 0.80 15.51 0.60 24.30 0.46 25.55 Embodiment 5 0.80 15.91 0.60 24.59 0.46 25.79 Competitive 1 1.06 1.27 1.01 3.36 0.94 1.61 Competitive 2 0.99 6.82 1.09 −1.10 0.80 12.80 Competitive 3 0.98 5.78 0.91 11.72 0.83 10.13 Competitive 4 0.98 6.63 1.02 3.40 1.06 0.17 Competitive 5 0.90 13.67 0.91 11.72 0.82 10.34 Competitive 6 1.06 0.61 1.08 −0.70 1.06 −4.03 Competitive 7 0.86 19.80 0.77 19.86 0.78 9.00 Competitive 8 1.10 0.72 1.08 0.87 1.05 1.08
  • From the data in Table 5, it may be seen that there is a difference in the slopes of the sets of prostheses of Embodiments 3, 4, and 5 as compared to the slopes of the sets of the other prostheses. In particular, it may be seen from the data in Table 5 that the sets of prostheses of Embodiments 3, 4, and 5 have a narrowing posterior M/L dimension with increasing A/P size, as indicated by slopes less than approximately 0.85, for example, as opposed to a substantially parallel or one-to-one relationship between the posterior M/L dimension and the A/P dimension with increasing A/P size as in the sets of other prostheses, as indicated by slopes of 0.86 and above. In exemplary embodiments, the slope of posterior M/L dimension with increasing A/P size for prostheses 50 may be as small as approximately 0.50, 0.55, 0.60, or 0.65 or as large as approximately 0.85, 0.84, 0.83, 0.81, 0.80, 0.75, or 0.70. In an exemplary embodiment, the slope of posterior M/L dimension with increasing A/P size for prostheses 50 is approximately 0.80. Thus, the posterior M/L dimension for prostheses 50 increases at a lesser rate than the corresponding overall A/P dimension. In contrast, in the sets of other prostheses, the posterior M/L dimension and the A/P dimension increase at substantially the same rate with increasing A/P size. In this manner, the sets of prostheses designed in accordance with the present invention offer a surgeon a unique combination of implant posterior M/L widths with varying A/P size for an overall system or set of prostheses, wherein such sets of prostheses are more anatomically optimized for the female anatomy as compared with the sets of other prostheses.
  • Furthermore, from the data in Table 5, it may be seen that there is a significant difference in slope for the sets of prostheses of Embodiments 3, 4, and 5 as compared with the slopes of the other sets of prostheses when looking at the B-B and MB dimensions. The magnitudes of the B-B values and MB values for a given A/P dimension are more pronounced, i.e., the variance in width at dimension B-B or MB over various A/P sizes between the sets of prostheses of Embodiments 3, 4, and 5 and the other sets of prostheses is more dramatically pronounced.
  • Specifically, sets of prostheses of Embodiments 3, 4, and 5 have a narrowing B-B M/L dimension with increasing A/P size, as indicated by slopes less than approximately 0.77, for example, as opposed to a substantially parallel or one-to-one relationship between the B-B M/L dimension and the A/P dimension with increasing A/P size as in the sets of other prostheses, as indicated by slopes of 0.78 and above. In exemplary embodiments, the slope of the B-B M/L dimension with increasing A/P size for prostheses 50 may be as small as approximately 0.30, 0.35, 0.40, or 0.45 or as large as 0.77, 0.76, 0.75, 0.74, 0.72, 0.70, 0.65, 0.60, or 0.50. In an exemplary embodiment, the slope is of the B-B M/L dimension with increasing A/P size for prostheses 50 is approximately 0.46. Thus, the B-B M/L dimension for prostheses 50 increases at a lesser rate than the corresponding overall A/P dimension. In contrast, in the sets of other prostheses, the B-B M/L dimension and the A/P dimension increase at substantially the same rate with increasing A/P size.
  • Furthermore, sets of prostheses of Embodiments 3, 4, and 5 have a narrowing MB M/L dimension with increasing A/P size, as indicated by slopes less than 0.76, for example, as opposed to a substantially parallel or one-to-one relationship between the MB M/L dimension and the A/P dimension with increasing A/P size as in the sets of other prostheses, as indicated by slopes of 0.77 and above. In exemplary embodiments, the slope of the MB M/L dimension with increasing A/P size for prostheses 50 may be as small as approximately 0.40, 0.45, 0.50, 0.55, or 0.57 or as large as approximately 0.76, 0.75, 0.74, 0.73, 0.72, 0.71, 0.70, 0.65, or 0.60. In an exemplary embodiment, the slope of the MB M/L dimension with increasing A/P size for prostheses 50 is approximately 0.60. Thus, the MB M/L dimension for prostheses 50 increases at a lesser rate than the corresponding overall A/P dimension. In contrast, in the sets of other prostheses, the MB M/L dimension and the A/P dimension increase at substantially the same rate with increasing A/P size.
  • In this manner, the prostheses designed in accordance with the present invention offer a surgeon a unique combination of implant M/L widths as an overall system of prostheses, wherein such sets of prostheses are more anatomically optimized for the female anatomy as compared with the sets of other prostheses.
  • Referring again to FIG. 6, the range of values for Embodiment 5 generally falls underneath a conceptual boundary, as shown by a solid dashed line. Clearly, no other prostheses have MB M/L dimensions that fall underneath this conceptual boundary for the MB M/L dimensions and corresponding Overall A/P dimensions. The boundary is essentially defined by two points defined by coordinates given by (Overall A/P dimension, MB Dimension): A first point (“First Point”)-(52.0, 55.0) and a second point (“Second Point”)-(77.0, 78.5). Thus, the boundary defined by First Point and Second Point may be given by the equation MB M/L=0.94*Overall A/P+6.12.
  • Referring again to FIG. 7, the range of values for Embodiment 5 generally falls underneath a conceptual boundary, as shown by a solid dashed line. Clearly, no other prostheses have B-B M/L dimensions that fall underneath this conceptual boundary for the B-B M/L dimensions and corresponding Overall A/P dimensions. The boundary is essentially defined by two points defined by coordinates given by (Overall A/P dimension, B-B Dimension): A first point (“First Point”)-(52.0, 49.0) and a second point (“Second Point”)-(77.0, 67.0). Thus, the boundary defined by First Point and Second Point may be given by the equation B-B M/L=0.72*Overall A/P+11.56.
  • As set forth in Table 6 below, the Overall A/P dimensions and the ratios of the dimensions “Posterior”, “MB”, and “B-B” vs. “Overall A/P” are given for Embodiments 3, 4, and 5 as well as for conventional prostheses Conventional 3, 4, and 5.
  • TABLE 6 Ratio Ratio Ratio Ratio Ratio Ratio (Posterior (MB (B-B (Posterior (MB (B-B M/L/ M/L/ M/L/ M/L/ M/L/ M/L/ Overall Overall Overall Overall Overall Overall Overall SIZE A/P A/P) A/P) A/P) Overall A/P A/P) A/P) A/P) Embodiment 4 Conventional 4 C 53.3 1.09 1.05 0.94 54.4 1.10 1.08 0.98 D 57.5 1.07 1.02 0.91 58.6 1.09 1.06 0.95 E 61.2 1.06 0.99 0.88 62.5 1.09 1.05 0.95 F 65.3 1.04 0.97 0.86 66.5 1.08 1.06 0.95 G 70.4 1.02 0.94 0.82 71.5 1.07 1.04 0.94 Embodiment 3 Conventional 3 C 52.3 1.11 1.07 0.96 53.5 1.12 1.09 1.00 D 56.4 1.09 1.04 0.92 57.6 1.11 1.08 0.97 E 60.2 1.08 1.01 0.90 61.5 1.11 1.07 0.96 F 64.2 1.06 0.99 0.87 65.5 1.10 1.07 0.97 G 69.4 1.03 0.95 0.84 70.5 1.09 1.05 0.95 Embodiment 5 Conventional 5 C 52.8 1.10 1.06 0.95 54.0 1.11 1.09 0.99 D 56.9 1.08 1.03 0.91 58.1 1.10 1.07 0.96 E 60.7 1.07 1.00 0.89 62.0 1.10 1.06 0.96 F 64.8 1.05 0.98 0.86 66.0 1.09 1.06 0.96 G 69.9 1.02 0.94 0.83 71.0 1.08 1.04 0.95
  • FIG. 9 is a graph of the ratio of (MB M/L/Overall A/P) vs. Overall A/P for some of the prostheses described above with respect to FIG. 6. FIG. 10 is a graph of the ratio of (B-B M/L/Overall A/P) vs. Overall A/P for some of the prostheses described above with respect to FIG. 7. FIG. 11 is a graph of the ratio of (Posterior M/L/Overall A/P) vs. Overall A/P for some of the prostheses described above with respect to FIG. 8.
  • Table 7 below sets forth the results of a first order equation fit to each of the data sets shown in FIGS. 9, 10, and 11 as well as for the data sets of Embodiments 3 and 4 and Conventional 3 and 4 in Table 6.
  • TABLE 7 Ratio (B-B M/L vs. Ratio (Posterior Overall M/L vs. Ratio (Mid-box A/P) vs. Overall A/P) M/L vs. Overall Overall A/P vs. Overall A/P) vs. Best Fit A/P Best Fit Overall A/P Regression Regression Best Fit Line Line Regression y- y- Line Inter- Implant Slope Intercept Slope y-Intercept Slope cept Conventional −0.0020 1.23 −0.0023 1.21 −0.0023 1.11 3 Conventional −0.0017 1.20 −0.0020 1.18 −0.0020 1.08 4 Conventional −0.0018 1.21 −0.0021 1.20 −0.0022 1.10 5 Embodiment −0.0044 1.34 −0.0068 1.42 −0.0071 1.33 3 Embodiment −0.0041 1.31 −0.0064 1.39 −0.0068 1.30 4 Embodiment −0.0042 1.32 −0.0066 1.41 −0.0069 1.31 5 Competitive −0.0003 1.10 −0.0008 1.11 −0.0004 0.99 1 Competitive −0.0017 1.20 0.0003 1.06 −0.0032 1.21 2 Competitive −0.0013 1.15 −0.0003 1.09 −0.0024 1.14 3 Competitive −0.0016 1.18 −0.0009 1.13 −0.0001 1.07 4 Competitive −0.0032 1.32 −0.0032 1.31 −0.0025 1.15 5 Competitive −0.0001 1.08 0.0001 1.06 0.0010 0.94 6 Competitive −0.0053 1.51 −0.0054 1.43 −0.0024 1.08 7 Competitive −0.0002 1.13 −0.0003 1.11 −0.0003 1.09 8
  • From the data in Table 7 it may be seen that there is a difference in the slopes of the sets of prostheses of Embodiments 3, 4, and 5 as compared to the slopes of the sets of the other prostheses. In particular, it may be seen from the data in Table 7 that the sets of prostheses of Embodiments 3, 4, and 5 have a narrowing posterior M/L dimension with increasing A/P size, as indicated by the slope of the ratio (posterior M/L/overall A/P) vs. overall A/P being less than −0.0032 for the sets of prostheses of Embodiments 3, 4, and 5 while the corresponding slope for the other sets of prostheses is greater than or equal to −0.0032, except for the Competitive 7 prosthesis, indicating that the sets of prostheses of Embodiments 3, 4, and 5 have an increasingly more pronounced narrowing of the posterior M/L dimension with increasing A/P size. In this manner, the sets of prostheses designed in accordance with the present invention offer a surgeon a unique combination of implant posterior M/L widths with varying A/P size for an overall system or set of prostheses, wherein such sets of prostheses are more anatomically optimized for the female anatomy as compared with the sets of other prostheses.
  • Furthermore, it may be seen that there is a significant difference in slope for the sets of prostheses of Embodiments 3, 4, and 5 as compared with the slopes of the other sets of prostheses when looking at the MB and B-B M/L dimensions. The magnitudes of the anterior M/L “B-B” values for a given A/P dimension are more pronounced, i.e., the variance in width at dimension B-B, namely, an anterior width, over various A/P sizes between the sets of prostheses of Embodiments 3, 4, and 5 and the other sets of prostheses is more dramatically pronounced. Specifically, the slope of the ratio (B-B M/L/overall A/P) vs. overall A/P is less than −0.0032 for the sets of prostheses of Embodiments 3, 4, and 5, while the corresponding slope for the other sets of prostheses is greater than or equal to −0.0032, indicating that the sets of prostheses of Embodiments 3, 4, and 5 have increasingly more pronounced narrowing of the B-B M/L dimension with increasing A/P size.
  • Furthermore, the slope of the ratio (MB M/L/Overall A/P) vs. Overall A/P is less than −0.0054 for the sets of prostheses of Embodiments 3, 4, and 5, while the corresponding slope for the other sets of prostheses is greater than or equal to −0.0054, indicating that the sets of prostheses of Embodiments 3, 4, and 5 have increasingly more pronounced narrowing of the B-B M/L dimension with increasing A/P size. Prostheses 50 may have slope values for the ratios of MB M/L/Overall A/P vs. Overall A/P with increasing A/P size which may be as small as −0.0075, −0.0072, −0.0069, −0.0066, or −0.0063 or as large as −0.0055, −0.0057, −0.0059, or −0.0061. In this manner, the prostheses designed in accordance with the present invention offer a surgeon a unique combination of implant M/L widths as an overall system of prostheses, wherein such sets of prostheses are more anatomically optimized for the female anatomy as compared with the sets of other prostheses.
  • Referring again to FIG. 9, the range of values for Embodiment 5 generally falls underneath a conceptual boundary, as shown with a solid dashed line. Clearly, no other prostheses have MB M/L/Overall A/P ratios that fall underneath this boundary for the MB M/L/Overall A/P ratios and corresponding Overall A/P dimensions. The boundary is defined by two points defined by coordinates given by (Overall A/P dimension, MB M/L/Overall A/P ratio): A first point (“First Point”)-(52.0, 1.06) and a second point (“Second Point”)-(77.0, 1.02). Thus, the boundary defined by First Point and Second Point may be given by the equation MB M/L/Overall A/P Ratio=−0.0015*Overall A/P+1.14.
  • Referring again to FIG. 10, the range of values for Embodiment 5 generally falls underneath a conceptual boundary, as shown with a solid dashed line. Clearly, no other prostheses have B-B M/L/Overall A/P ratios that fall underneath this boundary for the B-B M/L/Overall A/P ratios and corresponding Overall A/P dimensions. The boundary is defined by two points defined by coordinates given by (Overall A/P dimension, B-B M/L/Overall A/P ratio): A first point (“First Point”)-(52.0, 0.94) and a second point (“Second Point”)-(77.0, 0.87). Thus, the boundary defined by First Point and Second Point may be given by the equation B-B M/L/Overall A/P Ratio=−0.0029*Overall A/P+1.09.
  • As another exemplary comparison, the dimensions “A-A” and “Overall A/P” for conventional prostheses (“Conventional 3”, “Conventional 4”, and “Conventional 5” including five increasing sizes C through G) are compared with corresponding dimensions of a set of prostheses designed in accordance with the present invention (“Embodiment 3”, “Embodiment 4”, and “Embodiment 5” including five increasing sizes C through G). In one embodiment, the values for Conventional 5 and Embodiment 5 may be average values of Conventionals 3 and 4 and Embodiments 3 and 4, respectively. These values are presented in Table 8 below.
  • TABLE 8 SIZE Overall A/P A-A Overall A/P A-A Embodiment 4 Conventional 4 C 53.3 41.0 54.4 45.0 D 57.5 42.6 58.6 46.3 E 61.2 43.6 62.5 48.9 F 65.3 44.9 66.5 51.7 G 70.4 46.1 71.5 56.0 Embodiment 3 Conventional 3 C 52.3 41.0 53.5 45.0 D 56.4 42.6 57.6 46.4 E 60.2 43.6 61.5 48.5 F 64.2 44.9 65.5 51.6 G 69.4 46.1 70.5 55.7 Embodiment 5 Conventional 5 C 52.8 41.0 54.0 45.0 D 56.9 42.6 58.1 46.3 E 60.7 43.6 62.0 48.7 F 64.8 44.9 66.0 51.7 G 69.9 46.1 71.0 55.8
  • FIG. 18 is a graph of the dimension A-A M/L vs. overall A/P for the following sets of prostheses, each in increasing sizes C through G: Conventional 5, Embodiment 5, as well as eight other sets of competitive prostheses, designated Competitive 1, Competitive 2, Competitive 3, Competitive 4, Competitive 5, Competitive 6, Competitive 7, and Competitive 8.
  • Table 9 below sets forth the results of a first order equation fit to the data sets shown in FIG. 18 as well as for the data sets of Embodiments 3 and 4 and Conventional 3 and 4 in Table 8.
  • TABLE 9 A-A M/L vs. Overall A/P Best Fit Regression Line Implant Slope y-Intercept Conventional 3 0.64 9.66 Conventional 4 0.65 8.59 Conventional 5 0.65 9.13 Embodiment 3 0.30 25.78 Embodiment 4 0.30 25.47 Embodiment 5 0.30 25.63 Competitive 1 0.54 13.20 Competitive 2 0.46 19.33 Competitive 3 0.68 9.93 Competitive 4 0.76 6.05 Competitive 5 0.28 30.74 Competitive 6 0.86 2.98 Competitive 7 0.68 6.54 Competitive 8 0.69 10.46
  • From the data in Table 9, it may be seen that there is a difference in the slopes of the sets of prostheses of Embodiments 3, 4, and 5 as compared to the slopes of the sets of the other prostheses. In particular, it may be seen from the data in Table 9 that the sets of prostheses of Embodiments 3, 4, and 5 have a narrowing A-A M/L dimension with increasing A/P size, as indicated by slopes less than approximately 0.46, except for Competitive 5, for example, as opposed to a substantially parallel or one-to-one relationship between the posterior M/L dimension and the A/P dimension with increasing A/P size as in the sets of other prostheses, as indicated by slopes greater than or equal to 0.46. In an exemplary embodiment, the slope of A-A M/L dimension with increasing A/P size for prostheses 50 is approximately 0.30.
  • As set forth in Table 10 below, the Overall A/P dimensions and the ratios of the dimension “A-A” vs. “Overall A/P” are given for Embodiments 3, 4, and 5 as well as for conventional prostheses Conventional 3, 4, and 5.
  • TABLE 10 Ratio (A-A M/L/ Ratio (A-A M/L/ SIZE Overall A/P Overall A/P) Overall A/P Overall A/P) Embodiment 4 Conventional 4 C 53.3 0.77 54.4 0.83 D 57.5 0.74 58.6 0.79 E 61.2 0.71 62.5 0.78 F 65.3 0.69 66.5 0.78 G 70.4 0.66 71.5 0.78 Embodiment 3 Conventional 3 C 52.3 0.78 53.5 0.84 D 56.4 0.76 57.6 0.81 E 60.2 0.72 61.5 0.79 F 64.2 0.70 65.5 0.79 G 69.4 0.66 70.5 0.79 Embodiment 5 Conventional 5 C 52.8 0.78 54.0 0.83 D 56.9 0.75 58.1 0.80 E 60.7 0.72 62.0 0.78 F 64.8 0.69 66.0 0.78 G 69.9 0.66 71.0 0.79
  • FIG. 19 is a graph of the ratio of (A-A M/L/Overall A/P) vs. Overall A/P for the prostheses described above with respect to FIG. 18.
  • Table 11 below sets forth the results of a first order equation fit to the data sets shown in FIG. 19 as well as for the data sets of Embodiments 3 and 4 and Conventional 3 and 4 in Table 10.
  • TABLE 11 Ratio (A-A M/L vs. Overall A/P) vs. Overall A/P Best Fit Regression Line Implant Slope y-Intercept Conventional 3 −0.0027 0.97 Conventional 4 −0.0023 0.94 Conventional 5 −0.0025 0.95 Embodiment 3 −0.0071 1.15 Embodiment 4 −0.0067 1.13 Embodiment 5 −0.0069 1.14 Competitive 1 −0.0031 0.94 Competitive 2 −0.0049 1.08 Competitive 3 −0.0024 0.99 Competitive 4 −0.0016 0.96 Competitive 5 −0.0073 1.24 Competitive 6 0.0007 0.77 Competitive 7 −0.0019 0.90 Competitive 8 −0.0032 1.06
  • From the data in Table 11 it may be seen that there is a difference in the slopes of the sets of prostheses of Embodiments 3, 4, and 5 as compared to the slopes of the sets of the other prostheses. In particular, it may be seen from the data in Table 7 that the sets of prostheses of Embodiments 3, 4, and 5 have a narrowing A-A M/L dimension with increasing A/P size, as indicated by the slope of the ratio (A-A M/L/overall A/P) vs. overall A/P being less than −0.0049, for the sets of prostheses of Embodiments 3, 4, and 5 while the corresponding slope for the other sets of prostheses is greater than or equal to −0.0049, except for the Competitive 5 prosthesis, indicating that the sets of prostheses of Embodiments 3, 4, and 5 have an increasingly more pronounced narrowing of the A-A M/L dimension with increasing A/P size. In this manner, the sets of prostheses designed in accordance with the present invention offer a surgeon a unique combination of implant A-A M/L widths with varying A/P size for an overall system or set of prostheses, wherein such sets of prostheses are more anatomically optimized for the female anatomy as compared with the sets of other prostheses.
  • Referring again to FIG. 18, the range of values for Embodiment 5 generally falls below the line of a conceptual boundary. The boundary may be defined by two points defined by coordinates given by (Overall A/P dimension, A-A M/L dimension): a First Point (52.0, 40.3) and a Second Point (77.0, 51.8). Thus, the boundary defines a line given by the following equation: A-A M/L=0.46*Overall A/P+16.38.
  • Referring again to FIG. 19, the range of values for Embodiment 5 generally falls below the line of a conceptual boundary. The boundary may be defined by two points defined by coordinates given by (Overall A/P dimension, A-A M/L/Overall A/P ratio): a First Point (52.0, 0.78) and a Second Point (77.0, 0.67). Thus, the boundary defines a line given by the following equation: A-A M/L/Overall A/P=−0.0041*Overall A/P+0.99.
  • Another way of characterizing the design of the present prostheses is by distal taper angle, “DT”. As used herein and referring to FIG. 12, in which the profile 86 of prosthesis 50 is superimposed upon profile 88 of a prosthesis, the distal taper angle “DT” is the angle between two lines on opposite sides of the prosthesis each connecting a point 90 on the edge of the anterior distal chamfer, i.e., along dimension “B-B” and a point 92 on the edge of the posterior distal chamfer, i.e., along dimension “C-C”. In FIG. 12, distal taper angles DT1 and DT2 for prosthesis 50 and for another prosthesis are illustrated, respectively. It may be seen from FIG. 12 that the distal taper angle DT1 for prosthesis 50 is greater than the distal taper angle DT2 for the other prosthesis.
  • FIG. 13 is a chart of distal taper angle vs. overall A/P for several of the prostheses described above. As before, a first order curve fit was applied to the data in FIG. 13 and the results are set forth below in Table 12.
  • TABLE 12 Distal Taper Angle vs. Overall A/P Best fit regression line Equation Slope Conventional 3 y = 0.01x + 18.72 0.01 Conventional 4 y = 0.01x + 18.79 0.01 Conventional 5 y = 0.01x + 17.75 0.01 Embodiment 3 y = 0.28x + 7.10 0.28 Embodiment 4 y = 0.28x + 6.80 0.28 Embodiment 5 y = 0.28x + 6.95 0.28 Competitive 1 y = −0.15x + 24.81 −0.15 Competitive 2 y = 0.20x + 3.04 0.20 Competitive 3 y = −0.08x + 19.43 −0.08 Competitive 4 y = −0.24x + 18.77 −0.24 Competitive 5 y = −0.18x + 33.07 −0.18 Competitive 6 y = −0.19x + 21.99 −0.19 Competitive 7 y = −0.48x + 67.89 −0.48 Competitive 8 y = 0.07x + 3.42 0.07
  • As may be seen from the data in Table 12, the ratio between distal taper angle and overall A/P of the prostheses of Embodiments 3-5 differs from the other prostheses. In particular, the foregoing data indicates that prostheses of Embodiments 3-5 have a more pronounced and consistent increase in distal taper angle with increasing A/P size, as evidenced by a slope of greater than 0.20. Additionally, as may be seen from FIG. 13, the set of prostheses of Embodiment 5 has greater distal taper angles throughout the range of sizes of the prostheses than the other sets of prostheses with positive slopes as set forth in Table 12. Further, the distal taper angle curve for the set of prostheses of Embodiment 5 has a consistent upward slope as opposed to the randomized “see-saw” curves or flattened curves of the other sets of prostheses, indicating a more precise, parallel or substantial one-to-one relationship between distal taper angle and overall A/P with increasing A/P size for the set of prostheses of Embodiment 5. In exemplary embodiments, the slope of the distal taper angle with increasing A/P size for prostheses 50 may be as small as approximately 0.21, 0.22, 0.23, 0.24, 0.25, 0.26, 0.27, or 0.30 or as large as approximately 0.42, 0.39, 0.36, or 0.33. In an exemplary embodiment, the slope of the distal taper angle with increasing A/P size for prostheses 50 is approximately 0.28.
  • As shown in FIG. 13, the range of values for Embodiment 5 generally fall within the lines of a conceptual boundary, such as a four-sided polygon, as shown in solid dashed lines. Clearly, no other prostheses have distal taper angle values that fall within this range of values for the distal taper angle and corresponding Overall A/P dimensions. The four-sided polygon is essentially defined by four points defined by coordinates given by (Overall A/P dimension, Distal Taper Angle): An upper left corner (“1B”)-(52.0, 27.0°); A lower left corner (“4”)-(58.0, 22.5°); An upper right corner (“2”)-(77.0, 32.0°); and a lower right corner (“3”)-(77.0, 26.0°). Alternatively, the upper left corner may be at coordinates (52.0, 34.0°) (“1A”). Alternatively, points 1A, 1B, 2, 3, and 4 define a five-sided polygon which defines the conceptual boundary. The distal taper angles for Embodiment 5 may be approximately equal to or greater than 21°. The values of distal taper angles for prostheses 50 may be as small as approximately 21°, 22°, 23°, 25°, or 27, or as large as approximately 35°, 33°, 31°, or 29°.
  • Referring again to FIG. 8, the sets of prostheses may be grouped into a standard aspect ratio category and a non-standard aspect ratio category. As used herein, the term “standard aspect ratio” describes a set of prostheses which, for overall A/P values ranging from approximately 52.0 mm to 77.0 mm, have corresponding posterior M/L dimensions which generally fall between an Upper Boundary and a Lower Boundary. The Upper Boundary and Lower Boundary may be defined by lines having points defined by coordinates given by (Overall A/P dimension, Posterior M/L dimension). The Upper Boundary may be defined by a line connecting a first or lower left point (“First Upper Point”)-(52.0, 59.0) and a second or upper right point (“Second Upper Point”)-(77.0, 83.5). The Lower Boundary may be defined by three exemplary boundaries. In one exemplary embodiment, Lower Boundary 1 may be defined by a line connecting a first or lower left point (“First Lower Point 1”)-(52.0, 51.0) and a second or upper right point (“Second Lower Point 1”)-(77.0, 73.0). In another exemplary embodiment, Lower Boundary 2 may be defined by a line connecting a first or lower left point (“First Lower Point 2”)-(52.0, 53.0) and a second or upper right point (“Second Lower Point 2”)-(77.0, 75.0). In yet another exemplary embodiment, Lower Boundary 3 may be defined by a line connecting a first or lower left point (“First Lower Point 3”)-(52.0, 55.0) and a second or upper right point (“Second Lower Point 3”)-(77.0, 77.0). For prostheses having overall A/P values ranging from approximately 52.0 mm to 77.0 mm, the following equations may define the Upper and Lower Boundaries: the Upper Boundary line may be defined by the following equation: Posterior M/L=0.98*Overall A/P+8.04; the Lower Boundary 1 line may be defined by the following equation: Posterior M/L=0.88*Overall A/P+5.24; the Lower Boundary 2 line may be defined by the following equation: Posterior M/L=0.88*Overall A/P+7.24; and the Lower Boundary 3 line may be defined by the following equation: Posterior M/L=0.88*Overall A/P+9.24.
  • Referring again to FIG. 11, the Upper Boundary and Lower Boundary described above which are used to define the standard aspect ratio category for sets of prostheses may also be used with the posterior M/L/Overall A/P ratio for overall A/P values ranging from approximately 52.0 mm to 77.0 mm. The Upper Boundary and Lower Boundary may be defined by lines having points defined by coordinates given by (Overall A/P dimension, Posterior M/L/Overall A/P Ratio). The Upper Boundary may be defined by a line connecting a first or lower left point (“First Upper Point”)-(52.0, 1.13) and a second or upper right point (“Second Upper Point”)-(77.0, 1.08). The Lower Boundary may be defined by three exemplary boundaries. Lower Boundary 1 may be defined by a line connecting a first or lower left point (“First Lower Point 1”)-(52.0, 0.98) and a second or upper right point (“Second Lower Point 1”)-(77.0, 0.95). Lower Boundary 2 may be defined by a line connecting a first or lower left point (“First Lower Point 2”)-(52.0, 1.02) and a second or upper right point (“Second Lower Point 2”)-(77.0, 0.97). Lower Boundary 3 may be defined by a line connecting a first or lower left point (“First Lower Point 3”)-(52.0, 1.06) and a second or upper right point (“Second Lower Point 3”)-(77.0, 1.00). For prostheses having overall A/P values ranging from approximately 52.0 mm to 77.0 mm, the following equations may define the Upper and Lower Boundaries: the Upper Boundary line may be defined by the following equation: Posterior M/L/Overall A/P=−0.0020*Overall A/P+1.24; the Lower Boundary 1 line may be defined by the following equation: Posterior M/L/Overall A/P=−0.0013*Overall A/P+1.05; the Lower Boundary 2 line may be defined by the following equation: Posterior M/L/Overall A/P=−0.0018*Overall A/P+1.11; and the Lower Boundary 3 line may be defined by the following equation: Posterior M/L/Overall A/P=−0.0023*Overall A/P+1.18.
  • Referring to FIGS. 8 and 11 and applying the foregoing definition of standard aspect ratio, it may be seen that the prostheses described by Competitive 5 and Competitive 7 fall within the non-standard aspect ratio category.
  • Referring again to FIG. 13, Embodiment 5 has a distal taper angle greater than or equal to 21°. In contrast, all other standard aspect ratio prostheses have a distal taper angle less than 21°.
  • Referring again to FIG. 6, Embodiment 5 has MB M/L dimensions below the boundary defined by a line connecting the First Point (52.0, 55.0) and the Second Point (77.0, 78.5). Thus, for the range of Overall A/P values between 52.0 and 77.0, Embodiment 5 has MB M/L dimensions which fall below the line given by the following equation: MB M/L=0.94*Overall A/P+6.12. In contrast, all other standard aspect ratio prostheses have MB M/L dimensions which fall above the line given by the foregoing equation.
  • Referring again to FIG. 9, Embodiment 5 has MB M/L/Overall A/P ratios below the boundary defined by a line connecting the First Point (52.0, 1.06) and the Second Point (77.0, 1.02). Thus, for the range of Overall A/P values between 52.0 and 77.0, Embodiment 5 has MB M/L/Overall A/P ratios which fall below the line given by the following equation: MB M/L/Overall A/P=−0.0015*Overall A/P+1.14. In contrast, all other standard aspect ratio prostheses have MB M/L/Overall A/P ratios which fall above the line given by the foregoing equation.
  • Referring again to FIG. 7, Embodiment 5 has B-B M/L dimensions below the boundary defined by a line connecting the Third Point (52.0, 50.0) and the Fourth Point (77.0, 70.5). Thus, for the range of Overall A/P values between 52.0 and 77.0, Embodiment 5 has B-B M/L dimensions which fall below the line given by the following equation: B-B M/L=0.82*Overall A/P+7.36. In contrast, all other standard aspect ratio prostheses have B-B M/L dimensions which fall above the line given by the foregoing equation.
  • Referring again to FIG. 10, Embodiment 5 has B-B M/L/Overall A/P ratios below the boundary defined by a line connecting the Third Point (52.0, 0.96) and the Fourth Point (77.0, 0.92). Thus, for the range of Overall A/P values between 52.0 and 77.0, Embodiment 5 has B-B M/L/Overall A/P ratios which fall below the line given by the following equation: B-B M/L/Overall A/P=−0.0018*Overall A/P+1.06. In contrast, all other standard aspect ratio prostheses have B-B M/L/Overall A/P ratios which fall above the line given by the foregoing equation.
  • Referring again to FIG. 18, Embodiment 5 has A-A M/L dimensions below the boundary defined by a line connecting the Third Point (52.0, 40.1) and the Fourth Point (77.0, 53.5). Thus, for the range of Overall A/P values between 52.0 and 77.0, Embodiment 5 has A-A M/L dimensions which fall below the line given by the following equation: A-A M/L=0.54*Overall A/P+12.23. In contrast, all other standard aspect ratio prostheses have A-A M/L dimensions which fall above the line given by the foregoing equation.
  • Referring again to FIG. 19, Embodiment 5 has A-A M/L/Overall A/P ratios below the boundary defined by a line connecting the Third Point (52.0, 0.77) and the Fourth Point (77.0, 0.69). Thus, for the range of Overall A/P values between 52.0 and 77.0, Embodiment 5 has A-A M/L/Overall A/P ratios which fall below the line given by the following equation: A-A M/L/Overall A/P=−0.0031*Overall A/P+0.93. In contrast, all other standard aspect ratio prostheses have A-A M/L/Overall A/P ratios which fall above the line given by the foregoing equation.
  • Referring again to Table 5, Embodiments 3-5 have slopes of Posterior M/L dimension with increasing A/P size which are less than 0.98. Prostheses 50 may have slope values for the Posterior M/L dimension with increasing A/P size which may be as small as approximately 0.50, 0.55, 0.60, or 0.65 or as large as approximately 0.96, 0.95, 0.94, 0.91, 0.88, 0.85, 0.84, 0.83, 0.81, 0.80, 0.75, or 0.70. In contrast, all other standard aspect ratio prostheses have slopes of Posterior M/L dimension with increasing A/P size which are greater than or equal to 0.98.
  • Referring still to Table 5, Embodiments 3-5 have slopes of MB M/L dimension with increasing A/P size which are less than 0.91. Prostheses 50 may have slope values for the MB M/L dimension with increasing A/P size which may be as small as approximately 0.40, 0.45, 0.50, 0.55, or 0.57 or as large as approximately 0.90, 0.89, 0.87, 0.84, 0.81, 0.79, 0.76, 0.75, 0.74, 0.73, 0.72, 0.71, 0.70, 0.65, or 0.60. In contrast, all other standard aspect ratio prostheses have slopes of MB M/L dimension with increasing A/P size which are greater than or equal to 0.91.
  • Referring again to Table 5, Embodiments 3-5 have slopes of B-B M/L dimension with increasing A/P size which are less than 0.80. Prostheses 50 may have slope values for the B-B M/L dimension with increasing A/P size which may be as small as approximately 0.30, 0.35, 0.40, or 0.45 or as large as 0.79, 0.78, 0.77, 0.76, 0.75, 0.74, 0.72, 0.70, 0.65, 0.60, or 0.50. In contrast, all other standard aspect ratio prostheses have slopes of B-B M/L dimension with increasing A/P size which are greater than or equal to 0.80.
  • Referring to Table 9, Embodiments 3-5 have slopes of A-A M/L dimension with increasing A/P size which are less than 0.46. Prostheses 50 may have slope values for the A-A M/L dimension with increasing A/P size which may be as small as 0.15, 0.20, 0.25, or 0.30 or as large as 0.45, 0.44, 0.42, 0.40, 0.37, 0.34, or 0.31. In contrast, all other standard aspect ratio prostheses have slopes of A-A M/L dimension with increasing A/P size which are greater than or equal to 0.46.
  • Referring to Table 7, Embodiments 3-5 have slopes for the ratios of Posterior M/L/Overall A/P vs. Overall A/P with increasing A/P size which are less than −0.0020. Prostheses 50 may have slope values for the ratios of Posterior M/L/Overall A/P vs. Overall A/P with increasing A/P size which may be as small as −0.0060, −0.0055, −0.0050, −0.0045, −0.0040 or as large as −0.0021, −0.0022, −0.0025, −0.0030, or −0.0035. In contrast, all other standard aspect ratio prostheses have slopes for the ratios of Posterior M/L/Overall A/P vs. Overall A/P with increasing A/P size which are greater than or equal to −0.0020.
  • Referring again to Table 7, Embodiments 3-5 have slopes for the ratios of MB M/L/Overall A/P vs. Overall A/P with increasing A/P size which are less than −0.0023. Prostheses 50 may have slope values for the ratios of MB M/L/Overall A/P vs. Overall A/P with increasing A/P size which may be as small as −0.0075, −0.0072, −0.0069, −0.0066, or −0.0063 or as large as −0.0022, −0.0025, −0.0030, −0.0035, −0.0040, −0.0045, −0.0050, −0.0055, or −0.0060. In contrast, all other standard aspect ratio prostheses have slopes for the ratios of MB M/L/Overall A/P vs. Overall A/P with increasing A/P size which are greater than or equal to −0.0023.
  • Referring again to Table 7, Embodiments 3-5 have slopes for the ratios of B-B M/L/Overall A/P vs. Overall A/P with increasing A/P size which are less than −0.0032. Prostheses 50 may have slope values for the ratios of B-B M/L/Overall A/P vs. Overall A/P with increasing A/P size which may be as small as −0.0085, −0.0080, −0.0075, or −0.0070 or as large as −0.0031, −0.0032, −0.0034, −0.0037, −0.0040, −0.0045, −0.0050, −0.0055, −0.0060, or −0.0065. In an exemplary embodiment, the slope value for the ratio of B-B M/L/Overall A/P vs. Overall A/P with increasing A/P size is approximately −0.0069. In another exemplary embodiment, the slope value for the ratio of B-B M/L/Overall A/P vs. Overall A/P with increasing A/P size is approximately −0.0068. In yet another exemplary embodiment, the slope value for the ratio of B-B M/L/Overall A/P vs. Overall A/P with increasing A/P size is approximately −0.0071. In contrast, all other prostheses have slopes for the ratios of B-B M/L/Overall A/P vs. Overall A/P with increasing A/P size which are greater than or equal to −0.0032.
  • Referring again to Table 11, Embodiments 3-5 have slopes for the ratios of A-A M/L/Overall A/P vs. Overall A/P with increasing A/P size which are less than −0.0049. Prostheses 50 may have slope values for the ratios of A-A M/L/Overall A/P vs. Overall A/P with increasing A/P size which may be as small as −0.0080, −0.0075, −0.0070, or −0.0065 or as large as −0.0050, −0.0051, −0.0053, −0.0055, or −0.0060. In contrast, all other standard aspect ratio prostheses have slopes for the ratios of A-A M/L/Overall A/P vs. Overall A/P with increasing A/P size which are greater than or equal to −0.0049.
  • In accordance with another aspect of the present invention, the prosthesis 50 includes a recessed or reduced profile patellar sulcus as well as a thinned or reduced profile anterior flange condyles in comparison with other prostheses to alleviate the potential for the thicknesses of the patellar sulcus and the anterior flange condyles to be greater than the thickness of the femoral bone which is resected during the TKR/TKA procedure.
  • Referring to FIG. 14, a distal view of prosthesis 50 is shown, including sulcus 70 disposed between lateral and medial anterior condyles 66 and 68, respectively. FIG. 15 is a side view of prosthesis 50, in which the anterior profile of sulcus 70 of prosthesis 50 in accordance with the present invention is shown as curve 94, and the anterior profile of the sulcus of another prosthesis is represented by curve 96. A line parallel to non-articular anterior surface 76 and tangent to curve 94 or 96 at an anterior most point thereof may be used to define dimension D1. Dimension D1 represents the maximum thickness of sulcus 70, i.e., the width of sulcus 70 between non-articular anterior surface 76 and an anterior most point along curve 94 or curve 96. As may be seen from FIG. 15, curve 94 of sulcus 70 of prosthesis 50 is recessed, or shifted posteriorly, as compared to curve 96 of the sulcus of another prosthesis, wherein dimension D1 of prosthesis 50 is less than dimension D1 of the other prosthesis. Advantageously, recessing the patellar sulcus 70 of prostheses 50 will allow the patella to articulate slightly more posterior than in other prostheses which will reduce the likelihood of the thickness of the patellar sulcus to be greater than the thickness of the femoral bone which is resected when the joint is in extension and early flexion.
  • Referring to FIG. 16, the anterior profile of lateral or medial anterior condyle 66 or 68 of prosthesis 50 in accordance with the present invention is shown as curve 102, and the anterior profile of an anterior condyle of another prosthesis is shown as curve 104. Dimension D2 represents the maximum thickness, or depth, of one or both of the lateral and medial anterior condyles between non-articular anterior surface 76 and a line drawn parallel to surface 76 and tangent to curve 102 or curve 104 at an anterior most point thereof. As may be seen from FIG. 16, curve 102 of at least one of the lateral and medial anterior condyles 66 and 68 of prosthesis 50 is recessed, or shifted posteriorly, as compared to curve 104 of the anterior condyles of another prosthesis, wherein dimension D2 of prosthesis 50 is less than dimension D2 of the other prosthesis. Advantageously, the reduction of the anterior flange condyle thickness reduces the anterior flange profile and creates smoother, less abrupt changes in geometry as the condyles blend to the edges of the components while maintaining adequate height to prevent subluxation of the patella.
  • In Table 13 below, dimensions D1 and D2 described above are shown in accordance with a set of prostheses 50 (Embodiment 5) compared to another set of prostheses (Conventional 5), as well as the differences between dimensions D1 and D2 of the present prosthesis and other prosthesis. Unless otherwise indicated, all numerical dimensional values presented herein are in millimeters (“mm”)
  • TABLE 13 Differences (Conventional 5 − Embodiment Conventional Embodiment 5 5 5) SIZE “D1” “D2” “D1” “D2” “D1” “D2” C 2.5 5.1 3.5 6.3 1.0 1.1 D 2.5 5.3 3.6 6.4 1.0 1.1 E 2.6 5.0 3.6 6.2 1.1 1.2 F 2.5 5.3 3.6 6.4 1.1 1.1 G 3.2 6.4 4.2 7.3 1.1 0.9
  • As may be seen from Table 13, the sulcus and condyle thicknesses D1 and D2 respectively, of prostheses of Embodiment 5 are considerably reduced as compared to the other prostheses (Conventional 5). In particular, the sulcus thickness D1 of an exemplary embodiment may range from about 2.5 mm to 3.2 mm and the condyle thickness D2 may range from about 5.0 mm to 6.4 mm. In exemplary embodiments, the sulcus thickness D1 of prostheses 50 may be as small as approximately 2.5, 2.6, 2.7, or 2.8 mm or as large as approximately 3.2, 3.1, 3.0, or 2.9 mm. In exemplary embodiments, the condyle thickness D2 of prostheses 50 may be as small as approximately 4.0, 4.3, 4.7, 5.0, 5.2, 5.4, or 5.6 mm or as large as approximately 6.4, 6.2, 6.1, 6.0, or 5.8 mm.
  • The present prostheses further include a modified patellar sulcus tracking to further optimize conformance of the prostheses with female anatomy. The Q-angle (“quadriceps angle”) is formed in the frontal plane by a pair of line segments, one extending from the tibial tubercle to the middle of the patella and the other extending from the middle of the patella to the anterior superior iliac spine (ASIS). In adults, the Q-angle is typically 14° for males and 17° for females, wherein the Q-angle for females is approximately 3° more lateral than that of males. Responsive to this observation, and as described in detail below, the end point of the patellar sulcus 70 of prostheses 50 is shifted 3° laterally with respect to other prostheses, i.e., in an exemplary embodiment, lateralization angle 108 is approximately 7° in FIG. 17A and approximately 10° in FIG. 17B.
  • FIGS. 17A and 17B show A/P views of a prosthesis and prosthesis 50, respectively, with simulated patellas shown in FIGS. 17A and 17B as circular structures “PA” superimposed upon the anterior flanges of the prostheses. During articulation of the prosthesis, the patella will track within the patellar sulcus of the prosthesis. Referring to FIGS. 15, 17A, and 17B, the vertex 106 of lateralization angle 108 (FIGS. 17A and 17B) is located at the intersection of a plane coincident with the flat, distal non articular surface 80 (FIG. 15) of prosthesis 50 with curve 94 (FIG. 15) of the patellar sulcus 70. From vertex 106, line 110 is drawn orthogonal to distal non articular surface 80, and the end point 112 of the patellar sulcus 70 is defined as the center of the patellar sulcus 70 at a line 114 parallel to distal non articular surface 80 and disposed at varying heights “H” in accordance with varying prosthesis size. Line 118 connects vertex 106 with end point 112 of the patellar sulcus and the angle originating at vertex 106 between lines 110 and 118 is lateralization angle 108. For a range of sizes C through G of prostheses represented in FIGS. 17A and 17B having varying height dimensions “H” indicated in Table 14 below between distal non articular surface 80 and line 114, the distance between line 110 and point 112, i.e., the lateralization distance, also varies as indicated in FIGS. 17A and 17B, wherein the foregoing data is summarized below in Table 14 for a prosthesis (Conventional 1, FIG. 17A) and prosthesis 50 (Embodiment 1, FIG. 17B). Unless otherwise indicated, all numerical dimensional values presented herein are in millimeters (“mm”).
  • TABLE 14 Vertical Position Height From Lateralization Distance Change Distal Face Conventional 1 Embodiment 1 Conventional 1 − Size (H) (FIG. 17A) (FIG. 17B) Embodiment 1 C 28.6 3.8 5.3 1.5 D 31.3 4.1 5.8 1.7 E 31.3 4.2 5.8 1.6 F 34.8 4.5 6.5 2.0 G 38.8 5.0 7.0 2.0
  • As may be seen from Table 14, the lateralization distance of prostheses 50 is increased with respect to other prostheses to optimize patella tracking with the prostheses to more closely conform to female anatomy. In an exemplary embodiment, the lateralization distance is greater than 5.0 mm. In an exemplary embodiment, the lateralization distance for prostheses 50 may be as small as approximately 5.0, 5.3, 5.6, or 5.9 mm or as large as approximately 7.0, 6.7, 6.4, or 6.1 mm.
  • While this invention has been described as having exemplary designs, the present invention can be further modified within the spirit and scope of this disclosure. This application is therefore intended to cover any variations, uses, or adaptations of the invention using its general principles. Further, this application is intended to cover such departures from the present disclosure as come within known or customary practice in the art to which this invention pertains and which fall within the limits of the appended claims.

Claims (2)

1-6. (canceled)
7. A distal femoral prosthesis, comprising:
lateral and medial anterior condyles;
a non-articulating surface having a distal plane;
a patellar sulcus disposed between said lateral and medial anterior condyles, said sulcus having an end point located at a distance between 28.6 and 38.8 mm from said distal plane, said end point lateralized a distance between 5.3 and 7.0 mm from a line extending perpendicularly from said distal plane.
US12/974,018 2005-12-15 2010-12-21 Distal femoral knee prostheses Abandoned US20110093083A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US75061305P true 2005-12-15 2005-12-15
US80593306P true 2006-06-27 2006-06-27
US11/611,021 US9592127B2 (en) 2005-12-15 2006-12-14 Distal femoral knee prostheses
US11/780,248 US20080058947A1 (en) 2005-12-15 2007-07-19 Distal femoral knee prostheses
US12/974,018 US20110093083A1 (en) 2005-12-15 2010-12-21 Distal femoral knee prostheses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/974,018 US20110093083A1 (en) 2005-12-15 2010-12-21 Distal femoral knee prostheses

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/780,248 Continuation US20080058947A1 (en) 2005-12-15 2007-07-19 Distal femoral knee prostheses

Publications (1)

Publication Number Publication Date
US20110093083A1 true US20110093083A1 (en) 2011-04-21

Family

ID=37912410

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/611,021 Active 2029-09-01 US9592127B2 (en) 2005-12-15 2006-12-14 Distal femoral knee prostheses
US12/974,018 Abandoned US20110093083A1 (en) 2005-12-15 2010-12-21 Distal femoral knee prostheses

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/611,021 Active 2029-09-01 US9592127B2 (en) 2005-12-15 2006-12-14 Distal femoral knee prostheses

Country Status (7)

Country Link
US (2) US9592127B2 (en)
EP (1) EP1968497B1 (en)
JP (2) JP5275812B2 (en)
CN (1) CN101330883B (en)
AU (1) AU2006325787B2 (en)
CA (1) CA2641966C (en)
WO (1) WO2007070859A2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8551179B2 (en) 2011-06-16 2013-10-08 Zimmer, Inc. Femoral prosthesis system having provisional component with visual indicators
US8932365B2 (en) 2011-06-16 2015-01-13 Zimmer, Inc. Femoral component for a knee prosthesis with improved articular characteristics
US9060868B2 (en) 2011-06-16 2015-06-23 Zimmer, Inc. Femoral component for a knee prosthesis with bone compacting ridge
US9173744B2 (en) 2010-09-10 2015-11-03 Zimmer Gmbh Femoral prosthesis with medialized patellar groove
US9301845B2 (en) 2005-06-15 2016-04-05 P Tech, Llc Implant for knee replacement
US9308095B2 (en) 2011-06-16 2016-04-12 Zimmer, Inc. Femoral component for a knee prosthesis with improved articular characteristics
US9592127B2 (en) 2005-12-15 2017-03-14 Zimmer, Inc. Distal femoral knee prostheses
US10130375B2 (en) 2014-07-31 2018-11-20 Zimmer, Inc. Instruments and methods in performing kinematically-aligned total knee arthroplasty
US10136997B2 (en) 2015-09-29 2018-11-27 Zimmer, Inc. Tibial prosthesis for tibia with varus resection

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080058947A1 (en) * 2005-12-15 2008-03-06 Zimmer, Inc. Distal femoral knee prostheses
US7741612B2 (en) 2008-02-07 2010-06-22 General Electric Company Integrated neutron-gamma radiation detector with optical waveguide and neutron scintillating material
US8314399B2 (en) 2008-02-07 2012-11-20 General Electric Company Radiation detector with optical waveguide and neutron scintillating material
US8357202B2 (en) * 2009-12-22 2013-01-22 Zimmer, Gmbh J-curve for a femoral prosthesis component
FR2955482B1 (en) * 2010-01-27 2012-04-27 Claude Schwartz Prosthetic range of femoral components for knee prosthesis
US9498342B2 (en) * 2010-12-30 2016-11-22 Depuy Ireland Unlimited Company Knee prosthesis having commonly-sized patella components with varying thicknesses and peak surface diameters
GB201400287D0 (en) * 2014-01-08 2014-02-26 Depuy Ireland Femoral component of a knee joint prosthesis
CN105662657B (en) * 2015-06-02 2018-05-08 北京大学第三医院 A pro-type artificial knee femoral condyle match prosthesis

Citations (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081866A (en) * 1977-02-02 1978-04-04 Howmedica, Inc. Total anatomical knee prosthesis
US4340978A (en) * 1979-07-02 1982-07-27 Biomedical Engineering Corp. New Jersey meniscal bearing knee replacement
US4944756A (en) * 1988-02-03 1990-07-31 Pfizer Hospital Products Group Prosthetic knee joint with improved patellar component tracking
US5061271A (en) * 1989-02-27 1991-10-29 Boehringer Mannheim Corporation Tool for separating components of a modular joint prosthesis
US5133758A (en) * 1991-09-16 1992-07-28 Research And Education Institute, Inc. Harbor-Ucla Medical Center Total knee endoprosthesis with fixed flexion-extension axis of rotation
US5137536A (en) * 1990-03-16 1992-08-11 Nariko Koshino Tibial component for artificial knee joint
US5226915A (en) * 1992-04-03 1993-07-13 Bertin Kim C Femoral prosthesis component system for knee replacement surgery
US5282861A (en) * 1992-03-11 1994-02-01 Ultramet Open cell tantalum structures for cancellous bone implants and cell and tissue receptors
US5549686A (en) * 1994-06-06 1996-08-27 Zimmer, Inc. Knee prosthesis having a tapered cam
US5609643A (en) * 1995-03-13 1997-03-11 Johnson & Johnson Professional, Inc. Knee joint prosthesis
US5681354A (en) * 1996-02-20 1997-10-28 Board Of Regents, University Of Colorado Asymmetrical femoral component for knee prosthesis
US5688279A (en) * 1992-09-01 1997-11-18 Depuy Orthopedics, Inc. Alignment guide for a bone cutting block
US5776201A (en) * 1995-10-02 1998-07-07 Johnson & Johnson Professional, Inc. Modular femoral trial system
US5824105A (en) * 1994-08-04 1998-10-20 Smith & Nephew, Inc. Asymmetric femoral prosthesis
US5871546A (en) * 1995-09-29 1999-02-16 Johnson & Johnson Professional, Inc. Femoral component condyle design for knee prosthesis
US5935173A (en) * 1995-02-03 1999-08-10 Cryptych Pty Ltd Knee prosthesis
US6013103A (en) * 1996-07-11 2000-01-11 Wright Medical Technology, Inc. Medial pivot knee prosthesis
US6039764A (en) * 1997-08-18 2000-03-21 Arch Development Corporation Prosthetic knee with adjusted center of internal/external rotation
US6152960A (en) * 1998-10-13 2000-11-28 Biomedical Engineering Trust I Femoral component for knee endoprosthesis
US6197064B1 (en) * 1994-09-02 2001-03-06 Hudson Surgical Design, Inc. Prosthetic implant
US6264697B1 (en) * 1997-04-16 2001-07-24 Peter Stanley Walker Knee prosthesis having guide surfaces for control of anterior-posterior displacement
US6540787B2 (en) * 2000-02-24 2003-04-01 Aesculap Femoral component of a knee prosthetic including three curvature radii
US6540786B2 (en) * 1995-08-23 2003-04-01 Jean Chibrac Joint prosthesis members and method for making same
US6589283B1 (en) * 2001-05-15 2003-07-08 Biomet, Inc. Elongated femoral component
US20030158606A1 (en) * 2002-02-20 2003-08-21 Coon Thomas M. Knee arthroplasty prosthesis and method
US6616696B1 (en) * 1998-09-04 2003-09-09 Alan C. Merchant Modular knee replacement system
US20030225458A1 (en) * 2002-06-04 2003-12-04 Ron Donkers Universal femoral component for endoprosthetic knee
US20040039450A1 (en) * 2002-08-26 2004-02-26 Griner Adam M. Easily assembled provisional orthopaedic implant
US6699291B1 (en) * 1999-04-01 2004-03-02 Merck Biomaterial France Antero-postero-stabilized knee prosthesis
US20040172137A1 (en) * 2001-08-27 2004-09-02 Zimmer Technology, Inc. Femoral augments for use with knee joint prosthesis
US6802865B2 (en) * 2000-10-18 2004-10-12 Aesculap Tilted femoral component
US20040249467A1 (en) * 2001-01-29 2004-12-09 Meyers John E. Constrained prosthetic knee with rotating bearing
US20050102032A1 (en) * 2003-11-07 2005-05-12 University Of Vermont And State Agricultural College Knee joint prosthesis with a femoral component which links the tibiofemoral axis of rotation with the patellofemoral axis of rotation
US6893467B1 (en) * 1999-07-26 2005-05-17 Michel Bercovy Knee prosthesis
US20050107884A1 (en) * 2002-11-22 2005-05-19 Johnson Erin M. Modular knee prosthesis
US20050177169A1 (en) * 2004-02-06 2005-08-11 Synvasive Technology, Inc. Dynamic knee balancer
US20050283249A1 (en) * 2004-06-22 2005-12-22 Carson Christopher P Systems and processes for determining proper superior-inferior joint line positioning
US20060028773A1 (en) * 2004-08-04 2006-02-09 Tdk Corporation Magnetoresistive device, thin film magnetic head, head gimbal assembly, head arm assembly, magnetic disk drive and method of drive magnetoresistive device
US20060129246A1 (en) * 2004-10-20 2006-06-15 Zimmer Technology, Inc. Mobile bearing unicondylar knee prosthesis
US7081137B1 (en) * 2003-06-23 2006-07-25 Howmedica Osteonics Corp. Knee prosthesis with extended range of motion
US20060224244A1 (en) * 2005-03-31 2006-10-05 Zimmer Technology, Inc. Hydrogel implant
US20060235541A1 (en) * 2005-04-15 2006-10-19 Zimmer Technology, Inc. Bearing implant
US20060235542A1 (en) * 2005-04-15 2006-10-19 Zimmer Technology, Inc. Flexible segmented bearing implant
US20060287733A1 (en) * 2005-06-15 2006-12-21 Bonutti Peter M Gender specific implant and packaging
US20070088444A1 (en) * 2005-10-13 2007-04-19 Robert A Hodorek Method for repairing a bone defect using a formable implant which hardens in vivo
US20070123984A1 (en) * 2005-10-26 2007-05-31 Zimmer Technology, Inc. Ligament attachment and repair device
US20070135926A1 (en) * 2005-12-14 2007-06-14 Peter Walker Surface guided knee replacement
US20070179607A1 (en) * 2006-01-31 2007-08-02 Zimmer Technology, Inc. Cartilage resurfacing implant
US20070233269A1 (en) * 2001-05-25 2007-10-04 Conformis, Inc. Interpositional Joint Implant
US7306609B2 (en) * 1999-03-02 2007-12-11 Plus Orthopedics Ag Femoral slideway
US20080058948A1 (en) * 2006-06-12 2008-03-06 Jean-Francois Biegun Tricompartment prosthesis with reinforcement
US20080119940A1 (en) * 2002-12-20 2008-05-22 Otto Jason K High performance knee prostheses
US20080140212A1 (en) * 2001-05-15 2008-06-12 Robert Metzger Elongated femoral component
US7413577B1 (en) * 2005-09-22 2008-08-19 Howmedica Osteonics Corp. Total stabilized knee prosthesis with constraint
US20080243258A1 (en) * 2005-08-24 2008-10-02 Kantilal Hastimal Sancheti Knee Joint Prosthesis
US20080288080A1 (en) * 2005-08-24 2008-11-20 Kantilal Hastimal Sancheti Knee joint prosthesis
US20090036992A1 (en) * 2006-04-07 2009-02-05 Athanasios Tsakonas Total Knee Arthroplasty Endoprothesis with Third Condyle and Rotating Polyethylene Insert
US20090043395A1 (en) * 2005-07-14 2009-02-12 Takao Hotokebuchi Artificial knee joint
US20090062924A1 (en) * 2004-05-06 2009-03-05 Biomet Manufacturing Corp. Knee joint prosthesis
US20090222103A1 (en) * 2001-05-25 2009-09-03 Conformis, Inc. Articular Implants Providing Lower Adjacent Cartilage Wear
US20090265013A1 (en) * 2008-04-17 2009-10-22 Mandell Steven L Tibial component of an artificial knee joint
US20090265011A1 (en) * 2008-04-17 2009-10-22 Mandell Steven L Femoral component of an artificial knee joint
US20090306786A1 (en) * 2007-08-27 2009-12-10 Samuelson Kent M Systems and methods for providing deeper knee flexion capabilities for knee prosthesis patients
US20090306787A1 (en) * 2006-04-04 2009-12-10 Paul Charles Crabtree Trial coupler systems and methods
US20090319047A1 (en) * 2008-06-24 2009-12-24 Peter Stanley Walker Recess-ramp knee joint prosthesis
US20090319049A1 (en) * 2008-02-18 2009-12-24 Maxx Orthopedics, Inc. Total Knee Replacement Prosthesis With High Order NURBS Surfaces
US20090326666A1 (en) * 2008-06-30 2009-12-31 Wyss Joseph G Posterior stabilized orthopaedic prosthesis
US20090326665A1 (en) * 2008-06-30 2009-12-31 Wyss Joseph G Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature
US20090326667A1 (en) * 2008-06-30 2009-12-31 Williams John L Orthopaedic femoral component having controlled condylar curvature
US20090326663A1 (en) * 2008-06-30 2009-12-31 Shouchen Dun Orthopaedic knee prosthesis having increased axial-rotation
US20100036499A1 (en) * 2006-04-13 2010-02-11 Pinskerova Knee prosthesis
US20100036500A1 (en) * 2008-06-30 2010-02-11 Heldreth Mark A Orthopaedic knee prosthesis having controlled condylar curvature
US20100161067A1 (en) * 2008-12-23 2010-06-24 Aesculap Ag Knee prosthesis
US20100191298A1 (en) * 2009-01-29 2010-07-29 Zimmer, Inc. Apparatus and method for the extramedullary location of the mechanical axis of a femur
US20100305708A1 (en) * 2001-05-25 2010-12-02 Conformis, Inc. Patient Selectable Knee Joint Arthroplasty Devices
US20110022179A1 (en) * 2009-07-27 2011-01-27 Andriacchi Thomas P Knee replacement system and method for enabling natural knee movement
US20110144760A1 (en) * 2004-01-05 2011-06-16 Conformis, Inc. Patient-Specific and Patient-Engineered Orthopedic Implants
US20110218541A1 (en) * 2010-03-08 2011-09-08 Zimmer, Inc. Femoral cut guide
US8062377B2 (en) * 2001-03-05 2011-11-22 Hudson Surgical Design, Inc. Methods and apparatus for knee arthroplasty
US20110307067A1 (en) * 2006-10-31 2011-12-15 Roger Ryan Dees Trial femoral prosthesis and its use
US20120323335A1 (en) * 2011-06-16 2012-12-20 Zimmer, Inc. Femoral component for a knee prosthesis with improved articular characteristics
US20120323336A1 (en) * 2011-06-16 2012-12-20 Zimmer, Inc. Femoral component for a knee prosthesis with improved articular characteristics
US20120323337A1 (en) * 2011-06-16 2012-12-20 Zimmer, Inc. Femoral component for a knee prosthesis with improved articular characteristics
US20120323334A1 (en) * 2011-06-16 2012-12-20 Zimmer, Inc. Femoral prosthesis system
US20130006376A1 (en) * 2011-06-30 2013-01-03 Wogoman Thomas E Method of using a trialing system for a knee prosthesis
US20130006371A1 (en) * 2011-06-30 2013-01-03 Wogoman Thomas E System and method of trialing a knee prosthesis
US20130006370A1 (en) * 2011-06-30 2013-01-03 Wogoman Thomas E Trialing system for a knee prosthesis and method of use
US20130006378A1 (en) * 2011-06-30 2013-01-03 Wogoman Thomas E Polymer femoral trial component
US20130226305A1 (en) * 2010-09-10 2013-08-29 Zimmer Gmbh Femoral prosthesis with medialized patellar groove

Family Cites Families (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209861A (en) * 1978-02-22 1980-07-01 Howmedica, Inc. Joint prosthesis
DE2965891D1 (en) * 1978-03-10 1983-08-25 Biomedical Eng Corp Improved joint endoprosthesis
US4309778A (en) * 1979-07-02 1982-01-12 Biomedical Engineering Corp. New Jersey meniscal bearing knee replacement
CH657268A5 (en) * 1983-03-23 1986-08-29 Sulzer Ag Femoral component for a knee joint prosthesis.
DE3315401A1 (en) * 1983-04-28 1984-10-31 Feldmuehle Ag Knee endoprosthesis
JPS6468255A (en) 1987-08-10 1989-03-14 Dow Corning Wright Corp Artificial device for composing thighbone in knee joint
CA2006152C (en) 1988-12-27 1999-03-23 John Edward Slamin Modular knee prosthesis
US5007933A (en) 1989-01-31 1991-04-16 Osteonics Corp. Modular knee prosthesis system
JPH03131250A (en) * 1989-10-17 1991-06-04 Kawasaki Steel Corp Artificial knee joint
US7635390B1 (en) 2000-01-14 2009-12-22 Marctec, Llc Joint replacement component having a modular articulating surface
US5330532A (en) * 1990-11-09 1994-07-19 Chitranjan Ranawat Knee joint prosthesis
DE69220779D1 (en) 1992-04-30 1997-08-14 Merck Biomaterial France Back long shot stabilized knee prosthesis
US5728162A (en) * 1993-01-28 1998-03-17 Board Of Regents Of University Of Colorado Asymmetric condylar and trochlear femoral knee component
ES2070789B1 (en) * 1993-11-25 1996-01-01 Moure Carlos M Pichel Prosthesis joint rod ends and distal femur.
JP3267055B2 (en) 1994-05-31 2002-03-18 三菱マテリアル株式会社 Pure Au powder excellent gold clay production sinterability
FR2721500B1 (en) 1994-06-22 1996-12-06 Euros Sa femoral implant prosthesis including Tricompartimental knee.
FR2737970B1 (en) * 1995-08-23 1998-01-09 Chibrac Jean Elements of joint prosthesis and method of manufacturing thereof
JP3469972B2 (en) 1995-09-29 2003-11-25 京セラ株式会社 Artificial knee joint
JP3495161B2 (en) * 1995-11-30 2004-02-09 京セラ株式会社 The femoral component of an artificial knee joint
DE19646891A1 (en) 1996-11-13 1998-05-14 Kubein Meesenburg Dietmar Artificial joint, especially endoprosthesis for replacement of natural joints
DE19716879C2 (en) 1997-04-22 1999-07-15 Plus Endoprothetik Ag femoral
US6325828B1 (en) 1997-12-02 2001-12-04 Rose Biomedical Research Apparatus for knee prosthesis
DE19754079A1 (en) 1997-12-05 1999-06-10 Gmt Medizinische Technik Gmbh Endoprosthesis for at least partial replacement of a tibia
FR2784577B1 (en) 1998-10-16 2001-03-09 Depuy France Femoral implant recovery for knee prosthesis
US6106529A (en) 1998-12-18 2000-08-22 Johnson & Johnson Professional, Inc. Epicondylar axis referencing drill guide
US6712856B1 (en) * 2000-03-17 2004-03-30 Kinamed, Inc. Custom replacement device for resurfacing a femur and method of making the same
US8545569B2 (en) 2001-05-25 2013-10-01 Conformis, Inc. Patient selectable knee arthroplasty devices
US8480754B2 (en) 2001-05-25 2013-07-09 Conformis, Inc. Patient-adapted and improved articular implants, designs and related guide tools
GB0204381D0 (en) 2002-02-26 2002-04-10 Mcminn Derek J W Knee prosthesis
FR2838634B1 (en) 2002-04-19 2004-06-18 Cabinet Boettcher total knee prosthesis
DE10220591B4 (en) * 2002-05-08 2004-03-18 Mathys Medizinaltechnik Ag Joint prosthesis with intermediate element with different radii of curvature
EP1528902B1 (en) 2002-08-15 2006-11-15 Symbios Orthopédie SA Knee prosthesis
CA2501041A1 (en) 2002-10-07 2004-04-22 Conformis, Inc. Minimally invasive joint implant with 3-dimensional geometry matching the articular surfaces
JP4148316B2 (en) 2002-11-18 2008-09-10 株式会社神戸製鋼所 Artificial knee joint
US6770099B2 (en) 2002-11-19 2004-08-03 Zimmer Technology, Inc. Femoral prosthesis
JP4045194B2 (en) * 2003-02-25 2008-02-13 京セラ株式会社 Artificial knee joint
US7364590B2 (en) 2003-04-08 2008-04-29 Thomas Siebel Anatomical knee prosthesis
FR2854792B1 (en) 2003-05-12 2005-09-09 Tornier Sa prosthetic elements for a game set prosthetic tibial
EP1477142A3 (en) 2003-05-13 2005-01-05 Privelop AG Endoprosthesis of the knee
AU2004281743B2 (en) 2003-10-17 2011-06-09 Smith & Nephew, Inc. High flexion articular insert
US20090210066A1 (en) 2004-01-23 2009-08-20 The General Hospital Corporation Dba Massachusetts General Hospital Anterior cruciate ligament substituting knee replacement prosthesis
JP3915989B2 (en) 2004-03-17 2007-05-16 ナカシマプロペラ株式会社 Artificial knee joint
FR2871678B1 (en) 2004-06-17 2006-09-01 Transysteme Sa Total prosthesis of the knee
GB0510194D0 (en) 2005-05-19 2005-06-22 Mcminn Derek J W Knee prosthesis
AT398428T (en) * 2005-08-16 2008-07-15 Zimmer Gmbh operation system
AU2006313698B2 (en) 2005-11-09 2012-07-26 Zimmer Gmbh Implant
WO2007070859A2 (en) 2005-12-15 2007-06-21 Zimmer, Inc. Distal femoral knee prostheses
US20080058947A1 (en) * 2005-12-15 2008-03-06 Zimmer, Inc. Distal femoral knee prostheses
AU2007226924A1 (en) 2006-03-21 2007-09-27 Conformis, Inc. Interpositional joint implant
FR2901689B1 (en) 2006-05-30 2008-08-08 Dedienne Sante Sa Total prosthesis of the knee joint
US7695520B2 (en) 2006-05-31 2010-04-13 Biomet Manufacturing Corp. Prosthesis and implementation system
FR2901996B1 (en) 2006-06-12 2008-08-22 Jean Francois Biegun Femoral component for right or left knee
CN105748175A (en) 2006-09-06 2016-07-13 史密夫和内修有限公司 Instrumentation For Implants With Transition Surfaces And Related Processes
US7582118B2 (en) * 2007-02-06 2009-09-01 Zimmer Technology, Inc. Femoral trochlea prostheses
US8128704B2 (en) * 2007-02-06 2012-03-06 Zimmer, Inc. Femoral trochlea prostheses
US20080281428A1 (en) * 2007-05-07 2008-11-13 Zimmer, Inc. Methods and apparatuses for attaching soft tissue to orthopaedic implants
US9107769B2 (en) 2007-08-27 2015-08-18 Kent M. Samuelson Systems and methods for providing a femoral component
DE202007014128U1 (en) 2007-10-09 2008-01-10 Kloss, Henning Knee endoprosthesis
US20090132055A1 (en) 2007-11-08 2009-05-21 Ferro Thomas D Arthroplasty device
KR100901524B1 (en) 2008-01-08 2009-06-08 주식회사 코렌텍 Artificial knee joint apparatus having plural curvatures at a femoral component
KR100901528B1 (en) 2008-01-08 2009-06-08 주식회사 코렌텍 Artificial knee joint apparatus for preventing from damaging ligament
KR100930727B1 (en) 2008-01-08 2009-12-09 주식회사 코렌텍 Having an improved post and improved cam structure knee
KR20100136449A (en) 2008-02-18 2010-12-28 막스 오소페딕스, 아이엔씨. Total knee replacement prosthesis with high order nurbs surfaces
US8192498B2 (en) 2008-06-30 2012-06-05 Depuy Products, Inc. Posterior cructiate-retaining orthopaedic knee prosthesis having controlled condylar curvature
US8480753B2 (en) 2009-02-27 2013-07-09 Howmedica Osteonics Corp. Spot facing trochlear groove
WO2010108550A1 (en) 2009-03-27 2010-09-30 Smith & Nephew Orthopaedics Ag Artificial knee joint
DE102009029360A1 (en) 2009-09-10 2011-03-24 Aesculap Ag Knee endoprosthesis
JP5775092B2 (en) 2009-12-09 2015-09-09 ザ・ジエネラル・ホスピタル・コーポレーシヨン・ドウーイング・ビジネス・アズ・マサチユセツツ・ジエネラル・ホスピタル Implants that repair the normal range of knee flexion and movement
US8357202B2 (en) 2009-12-22 2013-01-22 Zimmer, Gmbh J-curve for a femoral prosthesis component
WO2012112701A2 (en) 2011-02-15 2012-08-23 Conformis, Inc. Patent-adapted and improved articular implants, designs, surgical procedures and related guide tools
CA2839433A1 (en) 2011-06-16 2012-12-20 Zimmer, Inc. Femoral component for a knee prosthesis with improved articular characteristics
US9289305B2 (en) 2011-08-03 2016-03-22 Joint Development, Llc Total knee arthroplasty with symmetric femoral implant having double Q-angle trochlear groove
US8409293B1 (en) 2011-10-26 2013-04-02 Sevika Holding AG Knee prosthesis
US8808387B2 (en) 2012-01-26 2014-08-19 Epic Ortho, LLC Prosthetic joint
US20140142713A1 (en) 2012-11-21 2014-05-22 Abraham P. Wright Knee prosthesis assembly having proportional trochlear groove geometry

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081866A (en) * 1977-02-02 1978-04-04 Howmedica, Inc. Total anatomical knee prosthesis
US4340978A (en) * 1979-07-02 1982-07-27 Biomedical Engineering Corp. New Jersey meniscal bearing knee replacement
US4944756A (en) * 1988-02-03 1990-07-31 Pfizer Hospital Products Group Prosthetic knee joint with improved patellar component tracking
US5061271A (en) * 1989-02-27 1991-10-29 Boehringer Mannheim Corporation Tool for separating components of a modular joint prosthesis
US5137536A (en) * 1990-03-16 1992-08-11 Nariko Koshino Tibial component for artificial knee joint
US5133758A (en) * 1991-09-16 1992-07-28 Research And Education Institute, Inc. Harbor-Ucla Medical Center Total knee endoprosthesis with fixed flexion-extension axis of rotation
US5326361A (en) * 1991-09-16 1994-07-05 Research And Education Institute, Inc. Total knee endoprosthesis with fixed flexion-extension axis of rotation
US5282861A (en) * 1992-03-11 1994-02-01 Ultramet Open cell tantalum structures for cancellous bone implants and cell and tissue receptors
US5226915A (en) * 1992-04-03 1993-07-13 Bertin Kim C Femoral prosthesis component system for knee replacement surgery
US5688279A (en) * 1992-09-01 1997-11-18 Depuy Orthopedics, Inc. Alignment guide for a bone cutting block
US5549686A (en) * 1994-06-06 1996-08-27 Zimmer, Inc. Knee prosthesis having a tapered cam
US5824105A (en) * 1994-08-04 1998-10-20 Smith & Nephew, Inc. Asymmetric femoral prosthesis
US6197064B1 (en) * 1994-09-02 2001-03-06 Hudson Surgical Design, Inc. Prosthetic implant
US5935173A (en) * 1995-02-03 1999-08-10 Cryptych Pty Ltd Knee prosthesis
US5609643A (en) * 1995-03-13 1997-03-11 Johnson & Johnson Professional, Inc. Knee joint prosthesis
US6540786B2 (en) * 1995-08-23 2003-04-01 Jean Chibrac Joint prosthesis members and method for making same
US5871546A (en) * 1995-09-29 1999-02-16 Johnson & Johnson Professional, Inc. Femoral component condyle design for knee prosthesis
US5776201A (en) * 1995-10-02 1998-07-07 Johnson & Johnson Professional, Inc. Modular femoral trial system
US5681354A (en) * 1996-02-20 1997-10-28 Board Of Regents, University Of Colorado Asymmetrical femoral component for knee prosthesis
US6013103A (en) * 1996-07-11 2000-01-11 Wright Medical Technology, Inc. Medial pivot knee prosthesis
US6264697B1 (en) * 1997-04-16 2001-07-24 Peter Stanley Walker Knee prosthesis having guide surfaces for control of anterior-posterior displacement
US6039764A (en) * 1997-08-18 2000-03-21 Arch Development Corporation Prosthetic knee with adjusted center of internal/external rotation
US6616696B1 (en) * 1998-09-04 2003-09-09 Alan C. Merchant Modular knee replacement system
US6152960A (en) * 1998-10-13 2000-11-28 Biomedical Engineering Trust I Femoral component for knee endoprosthesis
US7306609B2 (en) * 1999-03-02 2007-12-11 Plus Orthopedics Ag Femoral slideway
US6699291B1 (en) * 1999-04-01 2004-03-02 Merck Biomaterial France Antero-postero-stabilized knee prosthesis
US6893467B1 (en) * 1999-07-26 2005-05-17 Michel Bercovy Knee prosthesis
US6540787B2 (en) * 2000-02-24 2003-04-01 Aesculap Femoral component of a knee prosthetic including three curvature radii
US6802865B2 (en) * 2000-10-18 2004-10-12 Aesculap Tilted femoral component
US20040249467A1 (en) * 2001-01-29 2004-12-09 Meyers John E. Constrained prosthetic knee with rotating bearing
US8062377B2 (en) * 2001-03-05 2011-11-22 Hudson Surgical Design, Inc. Methods and apparatus for knee arthroplasty
US8088167B2 (en) * 2001-03-05 2012-01-03 Hudson Surgical Design, Inc. Femoral prosthetic implant
US20080140212A1 (en) * 2001-05-15 2008-06-12 Robert Metzger Elongated femoral component
US6589283B1 (en) * 2001-05-15 2003-07-08 Biomet, Inc. Elongated femoral component
US20070233269A1 (en) * 2001-05-25 2007-10-04 Conformis, Inc. Interpositional Joint Implant
US20100305708A1 (en) * 2001-05-25 2010-12-02 Conformis, Inc. Patient Selectable Knee Joint Arthroplasty Devices
US20100329530A1 (en) * 2001-05-25 2010-12-30 Conformis, Inc. Patient Selectable Knee Joint Arthroplasty Devices
US20090222103A1 (en) * 2001-05-25 2009-09-03 Conformis, Inc. Articular Implants Providing Lower Adjacent Cartilage Wear
US20040172137A1 (en) * 2001-08-27 2004-09-02 Zimmer Technology, Inc. Femoral augments for use with knee joint prosthesis
US20050283252A1 (en) * 2002-02-20 2005-12-22 Coon Thomas M Knee arthroplasty prosthesis and method
US20030158606A1 (en) * 2002-02-20 2003-08-21 Coon Thomas M. Knee arthroplasty prosthesis and method
US20050283251A1 (en) * 2002-02-20 2005-12-22 Coon Thomas M Knee arthroplasty prosthesis and method
US20050283253A1 (en) * 2002-02-20 2005-12-22 Coon Thomas M Knee arthroplasty prosthesis and method
US20050283250A1 (en) * 2002-02-20 2005-12-22 Coon Thomas M Knee arthroplasty prosthesis and method
US20030225458A1 (en) * 2002-06-04 2003-12-04 Ron Donkers Universal femoral component for endoprosthetic knee
US20040039450A1 (en) * 2002-08-26 2004-02-26 Griner Adam M. Easily assembled provisional orthopaedic implant
US20050107884A1 (en) * 2002-11-22 2005-05-19 Johnson Erin M. Modular knee prosthesis
US20100042224A1 (en) * 2002-12-20 2010-02-18 Smith & Nephew, Inc. High performance knee prostheses
US20080119940A1 (en) * 2002-12-20 2008-05-22 Otto Jason K High performance knee prostheses
US7081137B1 (en) * 2003-06-23 2006-07-25 Howmedica Osteonics Corp. Knee prosthesis with extended range of motion
US20050102032A1 (en) * 2003-11-07 2005-05-12 University Of Vermont And State Agricultural College Knee joint prosthesis with a femoral component which links the tibiofemoral axis of rotation with the patellofemoral axis of rotation
US20110144760A1 (en) * 2004-01-05 2011-06-16 Conformis, Inc. Patient-Specific and Patient-Engineered Orthopedic Implants
US20050177169A1 (en) * 2004-02-06 2005-08-11 Synvasive Technology, Inc. Dynamic knee balancer
US20090062924A1 (en) * 2004-05-06 2009-03-05 Biomet Manufacturing Corp. Knee joint prosthesis
US20050283249A1 (en) * 2004-06-22 2005-12-22 Carson Christopher P Systems and processes for determining proper superior-inferior joint line positioning
US20060028773A1 (en) * 2004-08-04 2006-02-09 Tdk Corporation Magnetoresistive device, thin film magnetic head, head gimbal assembly, head arm assembly, magnetic disk drive and method of drive magnetoresistive device
US20060129246A1 (en) * 2004-10-20 2006-06-15 Zimmer Technology, Inc. Mobile bearing unicondylar knee prosthesis
US20060224244A1 (en) * 2005-03-31 2006-10-05 Zimmer Technology, Inc. Hydrogel implant
US20060235541A1 (en) * 2005-04-15 2006-10-19 Zimmer Technology, Inc. Bearing implant
US20060235542A1 (en) * 2005-04-15 2006-10-19 Zimmer Technology, Inc. Flexible segmented bearing implant
US20060287733A1 (en) * 2005-06-15 2006-12-21 Bonutti Peter M Gender specific implant and packaging
US20090043395A1 (en) * 2005-07-14 2009-02-12 Takao Hotokebuchi Artificial knee joint
US20080243258A1 (en) * 2005-08-24 2008-10-02 Kantilal Hastimal Sancheti Knee Joint Prosthesis
US20080288080A1 (en) * 2005-08-24 2008-11-20 Kantilal Hastimal Sancheti Knee joint prosthesis
US7413577B1 (en) * 2005-09-22 2008-08-19 Howmedica Osteonics Corp. Total stabilized knee prosthesis with constraint
US20070088444A1 (en) * 2005-10-13 2007-04-19 Robert A Hodorek Method for repairing a bone defect using a formable implant which hardens in vivo
US20070123984A1 (en) * 2005-10-26 2007-05-31 Zimmer Technology, Inc. Ligament attachment and repair device
US20070135926A1 (en) * 2005-12-14 2007-06-14 Peter Walker Surface guided knee replacement
US20070179607A1 (en) * 2006-01-31 2007-08-02 Zimmer Technology, Inc. Cartilage resurfacing implant
US20090306787A1 (en) * 2006-04-04 2009-12-10 Paul Charles Crabtree Trial coupler systems and methods
US20090036992A1 (en) * 2006-04-07 2009-02-05 Athanasios Tsakonas Total Knee Arthroplasty Endoprothesis with Third Condyle and Rotating Polyethylene Insert
US20100036499A1 (en) * 2006-04-13 2010-02-11 Pinskerova Knee prosthesis
US20080058948A1 (en) * 2006-06-12 2008-03-06 Jean-Francois Biegun Tricompartment prosthesis with reinforcement
US20110307067A1 (en) * 2006-10-31 2011-12-15 Roger Ryan Dees Trial femoral prosthesis and its use
US20090306786A1 (en) * 2007-08-27 2009-12-10 Samuelson Kent M Systems and methods for providing deeper knee flexion capabilities for knee prosthesis patients
US20090319049A1 (en) * 2008-02-18 2009-12-24 Maxx Orthopedics, Inc. Total Knee Replacement Prosthesis With High Order NURBS Surfaces
US20090319048A1 (en) * 2008-02-18 2009-12-24 Maxx Orthopedics, Inc. Total Knee Replacement Prosthesis
US20090265013A1 (en) * 2008-04-17 2009-10-22 Mandell Steven L Tibial component of an artificial knee joint
US20090265011A1 (en) * 2008-04-17 2009-10-22 Mandell Steven L Femoral component of an artificial knee joint
US20090319047A1 (en) * 2008-06-24 2009-12-24 Peter Stanley Walker Recess-ramp knee joint prosthesis
US20090326665A1 (en) * 2008-06-30 2009-12-31 Wyss Joseph G Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature
US20090326667A1 (en) * 2008-06-30 2009-12-31 Williams John L Orthopaedic femoral component having controlled condylar curvature
US20100036500A1 (en) * 2008-06-30 2010-02-11 Heldreth Mark A Orthopaedic knee prosthesis having controlled condylar curvature
US20090326663A1 (en) * 2008-06-30 2009-12-31 Shouchen Dun Orthopaedic knee prosthesis having increased axial-rotation
US20090326666A1 (en) * 2008-06-30 2009-12-31 Wyss Joseph G Posterior stabilized orthopaedic prosthesis
US20100161067A1 (en) * 2008-12-23 2010-06-24 Aesculap Ag Knee prosthesis
US20100191298A1 (en) * 2009-01-29 2010-07-29 Zimmer, Inc. Apparatus and method for the extramedullary location of the mechanical axis of a femur
US20110022179A1 (en) * 2009-07-27 2011-01-27 Andriacchi Thomas P Knee replacement system and method for enabling natural knee movement
US20110218541A1 (en) * 2010-03-08 2011-09-08 Zimmer, Inc. Femoral cut guide
US20130226305A1 (en) * 2010-09-10 2013-08-29 Zimmer Gmbh Femoral prosthesis with medialized patellar groove
US8551179B2 (en) * 2011-06-16 2013-10-08 Zimmer, Inc. Femoral prosthesis system having provisional component with visual indicators
US20120323336A1 (en) * 2011-06-16 2012-12-20 Zimmer, Inc. Femoral component for a knee prosthesis with improved articular characteristics
US20120323337A1 (en) * 2011-06-16 2012-12-20 Zimmer, Inc. Femoral component for a knee prosthesis with improved articular characteristics
US20120323334A1 (en) * 2011-06-16 2012-12-20 Zimmer, Inc. Femoral prosthesis system
US20120323335A1 (en) * 2011-06-16 2012-12-20 Zimmer, Inc. Femoral component for a knee prosthesis with improved articular characteristics
US20130006371A1 (en) * 2011-06-30 2013-01-03 Wogoman Thomas E System and method of trialing a knee prosthesis
US20130006370A1 (en) * 2011-06-30 2013-01-03 Wogoman Thomas E Trialing system for a knee prosthesis and method of use
US20130006378A1 (en) * 2011-06-30 2013-01-03 Wogoman Thomas E Polymer femoral trial component
US20130006376A1 (en) * 2011-06-30 2013-01-03 Wogoman Thomas E Method of using a trialing system for a knee prosthesis

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9750612B2 (en) 2005-06-15 2017-09-05 P Tech, Llc Methods and systems for providing gender specific pharmaceuticals
US9301845B2 (en) 2005-06-15 2016-04-05 P Tech, Llc Implant for knee replacement
US9592127B2 (en) 2005-12-15 2017-03-14 Zimmer, Inc. Distal femoral knee prostheses
US9867708B2 (en) 2010-09-10 2018-01-16 Zimmer Gmbh Femoral prosthesis with lateralized patellar groove
US9173744B2 (en) 2010-09-10 2015-11-03 Zimmer Gmbh Femoral prosthesis with medialized patellar groove
US10322004B2 (en) 2010-09-10 2019-06-18 Zimmer Gmbh Femoral prosthesis with lateralized patellar groove
US9629723B2 (en) 2011-06-16 2017-04-25 Zimmer, Inc. Femoral component for a knee prosthesis with improved articular characteristics
EP2997936A3 (en) * 2011-06-16 2016-09-21 Zimmer, Inc. Femoral component for a knee prosthesis with improved articular characteristics
US9308095B2 (en) 2011-06-16 2016-04-12 Zimmer, Inc. Femoral component for a knee prosthesis with improved articular characteristics
US9060868B2 (en) 2011-06-16 2015-06-23 Zimmer, Inc. Femoral component for a knee prosthesis with bone compacting ridge
US8932365B2 (en) 2011-06-16 2015-01-13 Zimmer, Inc. Femoral component for a knee prosthesis with improved articular characteristics
US9993345B2 (en) 2011-06-16 2018-06-12 Zimmer, Inc. Femoral prosthesis system
US10045850B2 (en) 2011-06-16 2018-08-14 Zimmer, Inc. Femoral component for a knee prosthesis with improved articular characteristics
US10070966B2 (en) 2011-06-16 2018-09-11 Zimmer, Inc. Femoral component for a knee prosthesis with bone compacting ridge
US8551179B2 (en) 2011-06-16 2013-10-08 Zimmer, Inc. Femoral prosthesis system having provisional component with visual indicators
US10130375B2 (en) 2014-07-31 2018-11-20 Zimmer, Inc. Instruments and methods in performing kinematically-aligned total knee arthroplasty
US10136997B2 (en) 2015-09-29 2018-11-27 Zimmer, Inc. Tibial prosthesis for tibia with varus resection

Also Published As

Publication number Publication date
EP1968497B1 (en) 2016-03-16
JP2012000520A (en) 2012-01-05
US20170156872A1 (en) 2017-06-08
US9592127B2 (en) 2017-03-14
US20070260323A1 (en) 2007-11-08
CA2641966A1 (en) 2007-06-21
AU2006325787B2 (en) 2013-07-18
JP2009519781A (en) 2009-05-21
CN101330883A (en) 2008-12-24
JP5480223B2 (en) 2014-04-23
CN101330883B (en) 2013-03-13
WO2007070859A2 (en) 2007-06-21
JP5275812B2 (en) 2013-08-28
EP1968497A1 (en) 2008-09-17
AU2006325787A1 (en) 2007-06-21
CA2641966C (en) 2016-11-22

Similar Documents

Publication Publication Date Title
Gambirasio et al. Total elbow replacement for complex fractures of the distal humerus: an option for the elderly patient
EP0797417B1 (en) Knee prosthesis with shims
US6589283B1 (en) Elongated femoral component
US8128703B2 (en) Fixed-bearing knee prosthesis having interchangeable components
EP0449391B1 (en) Tool assembly for a prosthetic knee
US5035700A (en) Prosthetic knee joint with improved patellar component tracking
US6299645B1 (en) Dove tail total knee replacement unicompartmental
EP1398007B1 (en) Universal tibial augment
ES2456337T3 (en) Knee prosthesis
US7338524B2 (en) Surgically implantable knee prosthesis
ES2396228T3 (en) Patellar support implant
EP0732091B1 (en) Mobile bearing total joint replacement
US8834575B2 (en) Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature
US4207627A (en) Knee prosthesis
JP4559061B2 (en) Femoral component for an artificial knee joint
US8709091B2 (en) Tibial insert and associated surgical method
US20060030944A1 (en) Methods and apparatus for enhanced retention of prosthetic implants
CA2263086C (en) Four compartment knee
US8147558B2 (en) Mobile bearing assembly having multiple articulation interfaces
EP2319463B1 (en) Mobile tibial bearing assembly
US20050033424A1 (en) Surgically implantable knee prosthesis
EP1974697B1 (en) Mobile tibial bearing assembly
ES2614051T3 (en) orthopedic prostheses
US5171283A (en) Compound shape rotating bearing
EP0353921B1 (en) Tibial component for a replacement knee prosthesis

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION